{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:10:58Z","timestamp":1792552258676,"version":"4.5.0"},"reference-count":270,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP 23790744; JP 22484842"],"award-info":[{"award-number":["JP 23790744; JP 22484842"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP23gm1710010, JP22gm6110028"],"award-info":[{"award-number":["JP23gm1710010, JP22gm6110028"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"crossref","award":["JPMJMS2024"],"award-info":[{"award-number":["JPMJMS2024"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-025-01560-2","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T14:40:10Z","timestamp":1747665610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exploring \u03b1-Syn\u2019s Functions Through Ablation Models: Physiological and Pathological Implications"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8012-0068","authenticated-orcid":false,"given":"Anjali","family":"Praveen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1383-5691","authenticated-orcid":false,"given":"Godfried","family":"Dougnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4908-1035","authenticated-orcid":false,"given":"Hideaki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"1560_CR1","doi-asserted-by":"publisher","first-page":"9996958","DOI":"10.1155\/2021\/9996958","volume":"2021","author":"H Abdu","year":"2021","unstructured":"Abdu H, Tadese F, Seyoum G (2021) Comparison of ischemic and hemorrhagic stroke in the medical ward of Dessie Referral Hospital, Northeast Ethiopia: a retrospective study. Neurol Res Int 2021:9996958. https:\/\/doi.org\/10.1155\/2021\/9996958","journal-title":"Neurol Res Int"},{"issue":"1","key":"1560_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","volume":"25","author":"A Abeliovich","year":"2000","unstructured":"Abeliovich A, Schmitz Y, Fari\u00f1as I, Choi-Lundberg DL, Ho WH, Castillo PE, Shinsky N, Manuel J, Verdugo JM, Armanini M, Ryan A, Hynes M, Phillips H (2000) Mice lacking \u03b1-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25(1):239\u2013252. https:\/\/doi.org\/10.1016\/S0896-6273(00)80886-7","journal-title":"Neuron"},{"issue":"5","key":"1560_CR3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/jnc.14808","volume":"150","author":"P Alam","year":"2019","unstructured":"Alam P, Bousset L, Melki R, Otzen DE (2019) \u03b1-Synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities. J Neurochem 150(5):522\u2013534. https:\/\/doi.org\/10.1111\/jnc.14808","journal-title":"J Neurochem"},{"issue":"5","key":"1560_CR4","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.neurobiolaging.2008.11.001","volume":"31","author":"A Al-Wandi","year":"2010","unstructured":"Al-Wandi A, Ninkina N, Millership S, Williamson SJ, Jones PA, Buchman VL (2010) Absence of \u03b1-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice. Neurobiol Aging 31(5):796\u2013804. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.11.001","journal-title":"Neurobiol Aging"},{"issue":"7","key":"1560_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22413","volume":"9","author":"M Alwindi","year":"2023","unstructured":"Alwindi M, Bizanti A (2023) Vesicular monoamine transporter (VMAT) regional expression and roles in pathological conditions. Heliyon 9(7):e22413. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22413","journal-title":"Heliyon"},{"issue":"10","key":"1560_CR6","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1038\/s41418-020-0542-z","volume":"27","author":"PR Angelova","year":"2020","unstructured":"Angelova PR, Choi ML, Berezhnov AV, Horrocks MH, Hughes CD, De S, Rodrigues M, Yapom R, Little D, Dolt KS, Kunath T, Devine MJ, Gissen P, Shchepinov MS, Sylantyev S, Pavlov EV, Klenerman D, Abramov AY, Gandhi S (2020) Alpha-synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation. Cell Death Differ 27(10):2781\u20132796. https:\/\/doi.org\/10.1038\/s41418-020-0542-z","journal-title":"Cell Death Differ"},{"issue":"6","key":"1560_CR7","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/mds.25421","volume":"28","author":"S Appel-Cresswell","year":"2013","unstructured":"Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, Sherman H, Yu I, Shah B, Weir D, Thompson C, Szu-Tu C, Trinh J, Aasly JO, Rajput A, Rajput AH, Stoessl AJ, Farrer MJ (2013) Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson\u2019s disease. Mov Disord 28(6):811\u2013813. https:\/\/doi.org\/10.1002\/mds.25421","journal-title":"Mov Disord"},{"key":"1560_CR8","doi-asserted-by":"publisher","DOI":"10.1101\/2024.01.13.575526","author":"MR Arnold","year":"2024","unstructured":"Arnold MR, Cohn GM, Oxe KC, Elliott SN, Moore C, Laraia PV, Shekoohi S, Brownell D, Meshul CK, Witt SN, Larsen DH, Unni VK (2024) Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma. bioRxiv. https:\/\/doi.org\/10.1101\/2024.01.13.575526","journal-title":"bioRxiv"},{"issue":"40","key":"1560_CR9","doi-asserted-by":"publisher","first-page":"10558","DOI":"10.1523\/JNEUROSCI.1799-06.2006","volume":"26","author":"SA Austin","year":"2006","unstructured":"Austin SA, Floden AM, Murphy EJ, Combs CK (2006) \u03b1-Synuclein expression modulates microglial activation phenotype. J Neurosci 26(40):10558\u201310563. https:\/\/doi.org\/10.1523\/JNEUROSCI.1799-06.2006","journal-title":"J Neurosci"},{"issue":"6","key":"1560_CR10","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s11064-011-0439-9","volume":"36","author":"SA Austin","year":"2011","unstructured":"Austin SA, Rojanathammanee L, Golovko MY, Murphy EJ, Combs CK (2011) Lack of alpha-synuclein modulates microglial phenotype in vitro. Neurochem Res 36(6):994\u20131004. https:\/\/doi.org\/10.1007\/s11064-011-0439-9","journal-title":"Neurochem Res"},{"issue":"13","key":"1560_CR11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2113489119","volume":"119","author":"JI Ayers","year":"2022","unstructured":"Ayers JI, Lee J, Monteiro O, Woerman AL, Lazar AA, Condello C, Paras NA, Prusiner SB, Hurley JH (2022) Different \u03b1-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy. Proc Natl Acad Sci USA 119(13):e2113489119. https:\/\/doi.org\/10.1073\/pnas.2113489119","journal-title":"Proc Natl Acad Sci USA"},{"key":"1560_CR12","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba M, Nakajo S, Tu TT, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T (1998) Aggregation of \u03b1-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am J Pathol 152:879\u2013884","journal-title":"Am J Pathol"},{"key":"1560_CR13","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/nm.3885","volume":"21","author":"T Bachhuber","year":"2015","unstructured":"Bachhuber T, Katzmarski N, McCarter JF, Loreth D, Tahirovic S, Kamp F, Abou-Ajram C, Nuscher B, Serrano-Pozo A, M\u00fcller A, Prinz M, Steiner H, Hyman BT, Haass C, Meyer-Luehmann M (2015) Inhibition of amyloid-\u03b2 plaque formation by \u03b1-synuclein. Nat Med 21:802\u2013807. https:\/\/doi.org\/10.1038\/nm.3885","journal-title":"Nat Med"},{"key":"1560_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.freeradbiomed.2016.06.025","volume":"97","author":"S Baksi","year":"2016","unstructured":"Baksi S, Tripathi AK, Singh N (2016) Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson\u2019s disease. Free Radic Biol Med 97:292\u2013306. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.06.025","journal-title":"Free Radic Biol Med"},{"key":"1560_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000112832","volume":"5","author":"R Barbour","year":"2008","unstructured":"Barbour R, Kling K, Anderson JP, Banducci K, Cole T, Diep L, Fox M, Goldstein JM, Soriano F, Seubert P, Chilcote TJ (2008) Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis 5:55\u201359. https:\/\/doi.org\/10.1159\/000112832","journal-title":"Neurodegener Dis"},{"key":"1560_CR16","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/j.bpj.2010.06.035","volume":"99","author":"T Bartels","year":"2010","unstructured":"Bartels T, Ahlstrom LS, Leftin A, Kamp F, Haass C, Brown MF, Beyer K (2010) The N-terminus of the intrinsically disordered protein \u03b1-synuclein triggers membrane binding and helix folding. Biophys J 99:2116\u20132124. https:\/\/doi.org\/10.1016\/j.bpj.2010.06.035","journal-title":"Biophys J"},{"key":"1560_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fnmol.2018.00036","volume":"11","author":"MJ Benskey","year":"2018","unstructured":"Benskey MJ, Sellnow RC, Sandoval IM, Sortwell CE, Lipton JW, Manfredsson FP (2018) Silencing alpha synuclein in mature nigral neurons results in rapid neuroinflammation and subsequent toxicity. Front Mol Neurosci 11:36. https:\/\/doi.org\/10.3389\/fnmol.2018.00036","journal-title":"Front Mol Neurosci"},{"key":"1560_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073775","author":"M Bianchini","year":"2022","unstructured":"Bianchini M, Giambelluca M, Scavuzzo MC, Di Franco G, Guadagni S, Palmeri M, Furbetta N, Gianardi D, Costa A, Gentiluomo M, Gaeta R, Pollina LE, Falcone A, Vivaldi C, Di Candio G, Biagioni F, Busceti CL, Soldani P, Puglisi-Allegra S, Morelli L, Fornai F (2022) In pancreatic adenocarcinoma alpha-synuclein increases and marks peri-neural infiltration. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23073775","journal-title":"Int J Mol Sci"},{"key":"1560_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3233\/JPD-130203","volume":"3","author":"JM Bleasel","year":"2013","unstructured":"Bleasel JM, Hsiao JHT, Halliday GM, Kim WS (2013) Increased expression of ABCA8 in multiple system atrophy brain is associated with changes in pathogenic proteins. J Parkinsons Dis 3:331\u2013339. https:\/\/doi.org\/10.3233\/JPD-130203","journal-title":"J Parkinsons Dis"},{"key":"1560_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(95)12192-7","author":"D Blum-Degen","year":"1995","unstructured":"Blum-Degen D, M\u00fcller T, Kuhn W, Gerlach M, Przuntek H, Riederer P (1995) Interleukin-1\u03b2 and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease patients. Neurosci Lett. https:\/\/doi.org\/10.1016\/0304-3940(95)12192-7","journal-title":"Neurosci Lett"},{"key":"1560_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nchembio782","volume":"2","author":"DA Bosco","year":"2006","unstructured":"Bosco DA, Fowler DM, Zhang Q, Nieva J, Powers ET, Wentworth P, Lerner RA, Kelly JW (2006) Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate \u03b1-synuclein fibrilization. Nat Chem Biol 2:249\u2013253. https:\/\/doi.org\/10.1038\/nchembio782","journal-title":"Nat Chem Biol"},{"key":"1560_CR22","doi-asserted-by":"publisher","first-page":"22575","DOI":"10.1074\/jbc.M600288200","volume":"281","author":"CP Bracken","year":"2006","unstructured":"Bracken CP, Fedele AO, Linke S, Balrak W, Lisy K, Whitelaw ML, Peet DJ (2006) Cell-specific regulation of hypoxia-inducible factor (HIF)-1\u03b1 and HIF-2\u03b1 stabilization and transactivation in a graded oxygen environment. J Biol Chem 281:22575\u201322585. https:\/\/doi.org\/10.1074\/jbc.M600288200","journal-title":"J Biol Chem"},{"key":"1560_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01480-y","author":"JL Brown","year":"2022","unstructured":"Brown JL, Hart DW, Boyle GE, Brown TG, LaCroix M, Baraibar AM, Pelzel R, Kim M, Sherman MA, Boes S, Sung M, Cole T, Lee MK, Araque A, Lesn\u00e9 SE (2022) SNCA genetic lowering reveals differential cognitive function of alpha-synuclein dependent on sex. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/s40478-022-01480-y","journal-title":"Acta Neuropathol Commun"},{"key":"1560_CR24","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burr\u00e9","year":"2010","unstructured":"Burr\u00e9 J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, S\u00fcdhof TC (2010) \u03b1-Synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329:1663\u20131667. https:\/\/doi.org\/10.1126\/science.1195227","journal-title":"Science"},{"key":"1560_CR25","doi-asserted-by":"publisher","first-page":"29542","DOI":"10.1074\/jbc.M115.691592","volume":"290","author":"B Butler","year":"2015","unstructured":"Butler B, Saha K, Rana T, Becker JP, Sambo D, Davari P, Goodwin JS, Khoshbouei H (2015) Dopamine transporter activity is modulated by \u03b1-synuclein. J Biol Chem 290:29542\u201329554. https:\/\/doi.org\/10.1074\/jbc.M115.691592","journal-title":"J Biol Chem"},{"key":"1560_CR26","doi-asserted-by":"publisher","first-page":"14250","DOI":"10.1074\/jbc.M600922200","volume":"281","author":"BS Byoung","year":"2006","unstructured":"Byoung BS, Nakamaru-Ogiso E, Flotte TR, Matsuno-Yagi A, Yagi T (2006) In vivo complementation of complex I by the yeast Ndi1 enzyme: possible application for treatment of Parkinson disease. J Biol Chem 281:14250\u201314255. https:\/\/doi.org\/10.1074\/jbc.M600922200","journal-title":"J Biol Chem"},{"key":"1560_CR27","doi-asserted-by":"publisher","first-page":"8797","DOI":"10.1523\/JNEUROSCI.22-20-08797.2002","volume":"22","author":"DE Cabin","year":"2002","unstructured":"Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, McIlwain KL, Orrison B, Chen A, Ellis CE, Paylor R, Lu B, Nussbaum RL (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking \u03b1-synuclein. J Neurosci 22:8797\u20138807. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-20-08797.2002","journal-title":"J Neurosci"},{"key":"1560_CR28","doi-asserted-by":"publisher","first-page":"8923","DOI":"10.1523\/JNEUROSCI.1033-13.2013","volume":"33","author":"ES Calipari","year":"2013","unstructured":"Calipari ES, Ferris MJ (2013) Amphetamine mechanisms and actions at the dopamine terminal revisited. J Neurosci 33:8923\u20138925. https:\/\/doi.org\/10.1523\/JNEUROSCI.1033-13.2013","journal-title":"J Neurosci"},{"key":"1560_CR29","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/j.1471-4159.2005.03247.x","volume":"94","author":"PI Castagnet","year":"2005","unstructured":"Castagnet PI, Golovko MY, Barcel\u00f3-Coblijn GC, Nussbaum RL, Murphy EJ (2005) Fatty acid incorporation is decreased in astrocytes cultured from \u03b1-synuclein gene-ablated mice. J Neurochem 94:839\u2013849. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03247.x","journal-title":"J Neurochem"},{"key":"1560_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.brainres.2011.01.064","volume":"1382","author":"H Chadchankar","year":"2011","unstructured":"Chadchankar H, Ihalainen J, Tanila H, Yavich L (2011) Decreased reuptake of dopamine in the dorsal striatum in the absence of alpha-synuclein. Brain Res 1382:37\u201344. https:\/\/doi.org\/10.1016\/j.brainres.2011.01.064","journal-title":"Brain Res"},{"issue":"8","key":"1560_CR31","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2174\/1389202914666131210195808","volume":"14","author":"C Chai","year":"2013","unstructured":"Chai C, Lim KL (2013) Genetic insights into sporadic Parkinson\u2019s disease pathogenesis. Curr Genomics 14(8):486\u2013501. https:\/\/doi.org\/10.2174\/1389202914666131210195808","journal-title":"Curr Genomics"},{"issue":"41","key":"1560_CR32","doi-asserted-by":"publisher","first-page":"14966","DOI":"10.1073\/pnas.0406283101","volume":"101","author":"S Chandra","year":"2004","unstructured":"Chandra S, Fornai F, Kwon HB, Yazdani U, Atasoy D, Liu X et al (2004) Double-knockout mice for \u03b1- and \u03b2-synucleins: effect on synaptic functions. Proc Natl Acad Sci USA 101(41):14966\u201314971. https:\/\/doi.org\/10.1073\/pnas.0406283101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1560_CR33","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s11248-021-00286-3","volume":"30","author":"KD Chaprov","year":"2021","unstructured":"Chaprov KD, Lysikova EA, Teterina EV, Buchman VL (2021) Kinetics of alpha-synuclein depletion in three brain regions following conditional pan-neuronal inactivation of the encoding gene (Snca) by tamoxifen-induced Cre-recombination in adult mice. Transgenic Res 30(6):867\u2013873. https:\/\/doi.org\/10.1007\/s11248-021-00286-3","journal-title":"Transgenic Res"},{"issue":"2","key":"1560_CR34","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1021\/acschemneuro.8b00390","volume":"10","author":"LL Chen","year":"2019","unstructured":"Chen LL, Huang YJ, Cui JT, Song N, Xie J (2019) Iron dysregulation in Parkinson\u2019s disease: focused on the autophagy-lysosome pathway. ACS Chem Neurosci 10(2):863\u2013871. https:\/\/doi.org\/10.1021\/acschemneuro.8b00390","journal-title":"ACS Chem Neurosci"},{"issue":"8","key":"1560_CR35","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood-2012-07-442558","volume":"121","author":"SCC Chiang","year":"2013","unstructured":"Chiang SCC, Theorell J, Entesarian M, Meeths M, Mastafa M, Al-Herz W et al (2013) Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production. Blood 121(8):1345\u20131356. https:\/\/doi.org\/10.1182\/blood-2012-07-442558","journal-title":"Blood"},{"key":"1560_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113357","volume":"330","author":"E Cinar","year":"2020","unstructured":"Cinar E, Yalcin-Cakmakli G, Saka E, Ulusoy A, Yuruker S, Elibol B, Tel BC (2020) Modelling cognitive deficits in Parkinson\u2019s disease: is CA2 a gateway for hippocampal synucleinopathy? Exp Neurol 330:113357. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113357","journal-title":"Exp Neurol"},{"issue":"21","key":"1560_CR37","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","volume":"30","author":"LK Clinton","year":"2010","unstructured":"Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM (2010) Synergistic interactions between A\u03b2, tau, and \u03b1-synuclein: acceleration of neuropathology and cognitive decline. J Neurosci 30(21):7281\u20137289. https:\/\/doi.org\/10.1523\/JNEUROSCI.0490-10.2010","journal-title":"J Neurosci"},{"issue":"6","key":"1560_CR38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.135633","volume":"6","author":"TA Cole","year":"2021","unstructured":"Cole TA, Zhao H, Collier TJ, Sandoval I, Sortwell CE, Steece-Collier K et al (2021) \u03b1-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson\u2019s disease. JCI Insight 6(6):e135633. https:\/\/doi.org\/10.1172\/jci.insight.135633","journal-title":"JCI Insight"},{"issue":"12","key":"1560_CR39","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/mds.25978","volume":"29","author":"JM Cooper","year":"2014","unstructured":"Cooper JM, Wiklander PBO, Nordin JZ, Al-Shawi R, Wood MJ, Vithlani M et al (2014) Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov Disord 29(12):1476\u20131485. https:\/\/doi.org\/10.1002\/mds.25978","journal-title":"Mov Disord"},{"issue":"1","key":"1560_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11481-012-9410-z","volume":"8","author":"M Cosentino","year":"2013","unstructured":"Cosentino M, Marino F (2013) Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks? J Neuroimmune Pharmacol 8(1):163\u2013179. https:\/\/doi.org\/10.1007\/s11481-012-9410-z","journal-title":"J Neuroimmune Pharmacol"},{"issue":"3","key":"1560_CR41","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12640-009-9073-6","volume":"16","author":"L Crews","year":"2009","unstructured":"Crews L, Tsigelny I, Hashimoto M, Masliah E (2009) Role of synucleins in Alzheimer\u2019s disease. Neurotox Res 16(3):306\u2013317. https:\/\/doi.org\/10.1007\/s12640-009-9073-6","journal-title":"Neurotox Res"},{"key":"1560_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fnagi.2016.00038","volume":"8","author":"D Cutuli","year":"2016","unstructured":"Cutuli D, Pagani M, Caporali P, Galbusera A, Laricchiuta D, Foti F et al (2016) Effects of omega-3 fatty acid supplementation on cognitive functions and neural substrates: a voxel-based morphometry study in aged mice. Front Aging Neurosci 8:38. https:\/\/doi.org\/10.3389\/fnagi.2016.00038","journal-title":"Front Aging Neurosci"},{"issue":"22","key":"1560_CR43","doi-asserted-by":"publisher","first-page":"14524","DOI":"10.1073\/pnas.172514599","volume":"99","author":"W Dauer","year":"2002","unstructured":"Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, Larsen KE et al (2002) Resistance of \u03b1-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci U S A 99(22):14524\u201314529. https:\/\/doi.org\/10.1073\/pnas.172514599","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"1560_CR44","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","volume":"273","author":"WS Davidson","year":"1998","unstructured":"Davidson WS, Jonas A, Clayton DF, George JM (1998) Stabilization of \u03b1-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273(16):9443\u20139449. https:\/\/doi.org\/10.1074\/jbc.273.16.9443","journal-title":"J Biol Chem"},{"issue":"7","key":"1560_CR45","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1089\/ars.2015.6343","volume":"24","author":"E Deas","year":"2016","unstructured":"Deas E, Cremades N, Angelova PR, Ludtmann MHR, Yao Z, Chen S et al (2016) Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson\u2019s disease. Antioxid Redox Signal 24(7):376\u2013391. https:\/\/doi.org\/10.1089\/ars.2015.6343","journal-title":"Antioxid Redox Signal"},{"key":"1560_CR46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2741\/E835","volume":"10","author":"V Dhanraj","year":"2018","unstructured":"Dhanraj V, Karuppaiah J, Rengasamy B, Namasivayam E (2018) Myricetin attenuates neurodegeneration and cognitive impairment in Parkinsonism. Front Biosci (Elite Ed) 10:481\u2013494. https:\/\/doi.org\/10.2741\/E835","journal-title":"Front Biosci (Elite Ed)"},{"key":"1560_CR47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s40478-014-0150-6","volume":"2","author":"AS Don","year":"2014","unstructured":"Don AS, Hsiao J-HT, Bleasel JM, Couttas TA, Halliday GM, Kim WS (2014) Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy. Acta Neuropathol Commun 2:150. https:\/\/doi.org\/10.1186\/s40478-014-0150-6","journal-title":"Acta Neuropathol Commun"},{"issue":"s1","key":"1560_CR48","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the Parkinson pandemic. J Parkinsons Dis 8(s1):S3-8. https:\/\/doi.org\/10.3233\/JPD-181474","journal-title":"J Parkinsons Dis"},{"issue":"14","key":"1560_CR49","doi-asserted-by":"publisher","first-page":"7550","DOI":"10.3390\/ijms23147550","volume":"23","author":"G Dougnon","year":"2022","unstructured":"Dougnon G, Matsui H (2022) Modelling autism spectrum disorder (ASD) and attention-deficit\/hyperactivity disorder (ADHD) using mice and zebrafish. Int J Mol Sci 23(14):7550. https:\/\/doi.org\/10.3390\/ijms23147550","journal-title":"Int J Mol Sci"},{"issue":"17","key":"1560_CR50","doi-asserted-by":"publisher","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","volume":"285","author":"E Doxakis","year":"2010","unstructured":"Doxakis E (2010) Post-transcriptional regulation of \u03b1-synuclein expression by mir-7 and mir-153. J Biol Chem 285(17):12726\u201312734. https:\/\/doi.org\/10.1074\/jbc.M109.086827","journal-title":"J Biol Chem"},{"issue":"5","key":"1560_CR51","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.neuro.2004.05.002","volume":"25","author":"RE Drolet","year":"2004","unstructured":"Drolet RE, Behrouz B, Lookingland KJ, Goudreau JL (2004) Mice lacking \u03b1-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration. Neurotoxicology 25(5):761\u2013769. https:\/\/doi.org\/10.1016\/j.neuro.2004.05.002","journal-title":"Neurotoxicology"},{"issue":"6","key":"1560_CR52","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nsmb.1437","volume":"15","author":"DE Ehrnhoefer","year":"2008","unstructured":"Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R et al (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 15(6):558\u2013566. https:\/\/doi.org\/10.1038\/nsmb.1437","journal-title":"Nat Struct Mol Biol"},{"key":"1560_CR53","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1749-6632.2010.05906.x","volume":"1216","author":"LE Eiden","year":"2011","unstructured":"Eiden LE, Weihe E (2011) VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse. Ann N Y Acad Sci 1216:86\u201398. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05906.x","journal-title":"Ann N Y Acad Sci"},{"issue":"22","key":"1560_CR54","doi-asserted-by":"publisher","first-page":"10190","DOI":"10.1128\/mcb.25.22.10190-10201.2005","volume":"25","author":"CE Ellis","year":"2005","unstructured":"Ellis CE, Murphy EJ, Mitchell DC, Golovko MY, Scaglia F, Barcel\u00f3-Coblijn GC, Nussbaum RL (2005) Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking \u03b1-synuclein. Mol Cell Biol 25(22):10190\u201310201. https:\/\/doi.org\/10.1128\/mcb.25.22.10190-10201.2005","journal-title":"Mol Cell Biol"},{"key":"1560_CR55","doi-asserted-by":"publisher","first-page":"1012779","DOI":"10.3389\/fnagi.2022.1012779","volume":"14","author":"K Elman-Shina","year":"2022","unstructured":"Elman-Shina K, Efrati S (2022) Ischemia as a common trigger for Alzheimer\u2019s disease. Front Aging Neurosci 14:1012779. https:\/\/doi.org\/10.3389\/fnagi.2022.1012779","journal-title":"Front Aging Neurosci"},{"issue":"22","key":"1560_CR56","doi-asserted-by":"publisher","first-page":"10993","DOI":"10.1073\/pnas.89.22.10993","volume":"89","author":"JD Erickson","year":"1992","unstructured":"Erickson JD, Eiden LE, Hoffman BJ (1992) Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc Natl Acad Sci U S A 89(22):10993\u201310997. https:\/\/doi.org\/10.1073\/pnas.89.22.10993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1560_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.775382","volume":"8","author":"A Eynaudi","year":"2021","unstructured":"Eynaudi A, D\u00edaz-Castro F, B\u00f3rquez JC, Bravo-Sagua R, Parra V, Troncoso R (2021) Differential effects of oleic and palmitic acids on lipid droplet-mitochondria interaction in the hepatic cell line HepG2. Front Nutr 8:775382. https:\/\/doi.org\/10.3389\/fnut.2021.775382","journal-title":"Front Nutr"},{"issue":"5","key":"1560_CR58","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1021\/acs.jpclett.8b00092","volume":"9","author":"MAA Fakhree","year":"2018","unstructured":"Fakhree MAA, Nolten IS, Blum C, Claessens MMAE (2018) Different conformational subensembles of the intrinsically disordered protein \u03b1-synuclein in cells. J Phys Chem Lett 9(5):1249\u20131253. https:\/\/doi.org\/10.1021\/acs.jpclett.8b00092","journal-title":"J Phys Chem Lett"},{"key":"1560_CR59","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1039\/CT8946500899","volume":"65","author":"HJH Fenton","year":"1894","unstructured":"Fenton HJH (1894) Oxidation of tartaric acid in presence of iron. J Chem Soc Trans 65:899\u2013910. https:\/\/doi.org\/10.1039\/CT8946500899","journal-title":"J Chem Soc Trans"},{"key":"1560_CR60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3389\/fnmol.2019.00299","volume":"12","author":"CR Fields","year":"2019","unstructured":"Fields CR, Bengoa-Vergniory N, Wade-Martins R (2019) Targeting alpha-synuclein as a therapy for Parkinson\u2019s disease. Front Mol Neurosci 12:299. https:\/\/doi.org\/10.3389\/fnmol.2019.00299","journal-title":"Front Mol Neurosci"},{"key":"1560_CR61","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40478-021-01258-8","volume":"5","author":"DI Finkelstein","year":"2017","unstructured":"Finkelstein DI, Billings JL, Adlard PA, Ayton S, Sedjahtera A, Masters CL et al (2017) The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson\u2019s disease. Acta Neuropathol Commun 5:35. https:\/\/doi.org\/10.1186\/s40478-021-01258-8","journal-title":"Acta Neuropathol Commun"},{"key":"1560_CR62","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1073\/pnas.0409713102","volume":"102","author":"F Fornai","year":"2005","unstructured":"Fornai F, Schl\u00fcter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M et al (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and \u03b1-synuclein. Proc Natl Acad Sci U S A 102:3413\u20133418. https:\/\/doi.org\/10.1073\/pnas.0409713102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1560_CR63","doi-asserted-by":"publisher","first-page":"6559","DOI":"10.1038\/s41598-019-42902-7","volume":"9","author":"SC Foti","year":"2019","unstructured":"Foti SC, Hargreaves I, Carrington S, Kiely AP, Houlden H, Holton JL (2019) Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson\u2019s disease. Sci Rep 9:6559. https:\/\/doi.org\/10.1038\/s41598-019-42902-7","journal-title":"Sci Rep"},{"key":"1560_CR64","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1111\/j.1460-9568.2008.06527.x","volume":"28","author":"TM Fountaine","year":"2008","unstructured":"Fountaine TM, Venda LL, Warrick N, Christian HC, Brundin P, Channon KM et al (2008) The effect of \u03b1-synuclein knockdown on MPP+ toxicity in models of human neurons. Eur J Neurosci 28:2459\u20132473. https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06527.x","journal-title":"Eur J Neurosci"},{"key":"1560_CR65","doi-asserted-by":"publisher","first-page":"1456005","DOI":"10.3389\/fendo.2024.1456005","volume":"15","author":"Q Fu","year":"2024","unstructured":"Fu Q, Pan G, Yu Q, Liu Z, Shen T, Ma X et al (2024) Exploring the causal effects of serum lipids and lipidomes on Lewy body dementia: a Mendelian randomization study. Front Endocrinol (Lausanne) 15:1456005. https:\/\/doi.org\/10.3389\/fendo.2024.1456005","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1560_CR66","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) \u03b1-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164. https:\/\/doi.org\/10.1038\/ncb748","journal-title":"Nat Cell Biol"},{"key":"1560_CR67","doi-asserted-by":"publisher","first-page":"9610","DOI":"10.1038\/s41598-023-36451-3","volume":"13","author":"N Gajendran","year":"2023","unstructured":"Gajendran N, Rajasekaran S, Witt SN (2023) Knocking out alpha-synuclein in melanoma cells downregulates L1CAM and decreases motility. Sci Rep 13:9610. https:\/\/doi.org\/10.1038\/s41598-023-36451-3","journal-title":"Sci Rep"},{"key":"1560_CR68","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nchembio.1750","volume":"11","author":"C Galvagnion","year":"2015","unstructured":"Galvagnion C, Buell AK, Meisl G, Michaels TCT, Vendruscolo M, Knowles TPJ et al (2015) Lipid vesicles trigger \u03b1-synuclein aggregation by stimulating primary nucleation. Nat Chem Biol 11:229\u2013234. https:\/\/doi.org\/10.1038\/nchembio.1750","journal-title":"Nat Chem Biol"},{"key":"1560_CR69","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.expneurol.2013.07.015","volume":"248","author":"P Garcia-Reitboeck","year":"2013","unstructured":"Garcia-Reitboeck P, Anichtchik O, Dalley JW, Ninkina N, Tofaris GK, Buchman VL et al (2013) Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra. Exp Neurol 248:541\u2013545. https:\/\/doi.org\/10.1016\/j.expneurol.2013.07.015","journal-title":"Exp Neurol"},{"key":"1560_CR70","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12935-016-0361-y","volume":"16","author":"Y Ge","year":"2016","unstructured":"Ge Y, Xu K (2016) Alpha-synuclein contributes to malignant progression of human meningioma via the Akt\/mTOR pathway. Cancer Cell Int 16:50. https:\/\/doi.org\/10.1186\/s12935-016-0361-y","journal-title":"Cancer Cell Int"},{"key":"1560_CR71","doi-asserted-by":"publisher","first-page":"reviews3002","DOI":"10.1186\/gb-2001-3-1-reviews3002","volume":"3","author":"JM George","year":"2001","unstructured":"George JM (2001) The synucleins. Genome Biol 3:reviews3002. https:\/\/doi.org\/10.1186\/gb-2001-3-1-reviews3002","journal-title":"Genome Biol"},{"key":"1560_CR72","doi-asserted-by":"publisher","first-page":"8251","DOI":"10.1021\/bi0502137","volume":"44","author":"MY Golovko","year":"2005","unstructured":"Golovko MY, Faergeman NJ, Cole NB, Castagnet PI, Nussbaum RL, Murphy EJ (2005) \u03b1-Synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of \u03b1-synuclein palmitate binding. Biochemistry 44:8251\u20138259. https:\/\/doi.org\/10.1021\/bi0502137","journal-title":"Biochemistry"},{"key":"1560_CR73","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3390\/biom11050767","volume":"11","author":"PB Gon\u00e7alves","year":"2021","unstructured":"Gon\u00e7alves PB, Sodero ACR, Cordeiro Y (2021) Green tea epigallocatechin-3-gallate (EGCG) targeting protein misfolding in drug discovery for neurodegenerative diseases. Biomolecules 11:767. https:\/\/doi.org\/10.3390\/biom11050767","journal-title":"Biomolecules"},{"key":"1560_CR74","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/mt.2010.115","volume":"18","author":"OS Gorbatyuk","year":"2010","unstructured":"Gorbatyuk OS, Li S, Nash K, Gorbatyuk M, Lewin AS, Sullivan LF et al (2010) In vivo RNAi-mediated \u03b1-synuclein silencing induces nigrostriatal degeneration. Mol Ther 18:1450\u20131457. https:\/\/doi.org\/10.1038\/mt.2010.115","journal-title":"Mol Ther"},{"key":"1560_CR75","doi-asserted-by":"publisher","first-page":"19573","DOI":"10.1073\/pnas.1005005107","volume":"107","author":"B Greten-Harrison","year":"2010","unstructured":"Greten-Harrison B, Polydoro M, Morimoto-Tomita M, Diao L, Williams AM, Nie EH et al (2010) \u03b1\u03b2\u03b3-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction. Proc Natl Acad Sci U S A 107:19573\u201319578. https:\/\/doi.org\/10.1073\/pnas.1005005107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1560_CR76","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nsmb.1552","volume":"16","author":"S Gu","year":"2009","unstructured":"Gu S, Jin L, Zhang F, Sarnow P, Kay MA (2009) Biological basis for restriction of microRNA targets to the 3\u2032 untranslated region in mammalian mRNAs. Nat Struct Mol Biol 16:144\u2013150. https:\/\/doi.org\/10.1038\/nsmb.1552","journal-title":"Nat Struct Mol Biol"},{"key":"1560_CR77","doi-asserted-by":"publisher","first-page":"6824","DOI":"10.1038\/s41598-024-62910-6","volume":"14","author":"SC Gu","year":"2024","unstructured":"Gu SC, Xie ZG, Gu MJ, De WC, Xu LM, Gao C et al (2024) Myricetin mitigates motor disturbance and decreases neuronal ferroptosis in a rat model of Parkinson\u2019s disease. Sci Rep 14:6824. https:\/\/doi.org\/10.1038\/s41598-024-62910-6","journal-title":"Sci Rep"},{"key":"1560_CR78","doi-asserted-by":"publisher","first-page":"e12188","DOI":"10.15252\/emmm.202012188","volume":"13","author":"S Guhathakurta","year":"2021","unstructured":"Guhathakurta S, Kim J, Adams L, Basu S, Song MK, Adler E et al (2021) Targeted attenuation of elevated histone marks at SNCA alleviates \u03b1-synuclein in Parkinson\u2019s disease. EMBO Mol Med 13:e12188. https:\/\/doi.org\/10.15252\/emmm.202012188","journal-title":"EMBO Mol Med"},{"key":"1560_CR79","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/cns.14055","volume":"29","author":"M Guo","year":"2023","unstructured":"Guo M, Liu W, Luo H, Shao Q, Li Y, Gu Y et al (2023) Hypoxic stress accelerates the propagation of pathological alpha-synuclein and degeneration of dopaminergic neurons. CNS Neurosci Ther 29:544\u2013558. https:\/\/doi.org\/10.1111\/cns.14055","journal-title":"CNS Neurosci Ther"},{"key":"1560_CR80","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.3390\/molecules26113078","volume":"26","author":"IA Guschina","year":"2021","unstructured":"Guschina IA, Ninkina N, Roman A, Pokrovskiy MV, Buchman VL (2021) Triple-knockout, synuclein-free mice display compromised lipid pattern. Molecules 26:3078. https:\/\/doi.org\/10.3390\/molecules26113078","journal-title":"Molecules"},{"key":"1560_CR81","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1002\/cber.19320650507","volume":"64","author":"F Haber","year":"1931","unstructured":"Haber F, Willst\u00e4tter R (1931) Unpaarigkeit und Radikalketten im Reaktionsmechanismus organischer und enzymatischer Vorg\u00e4nge. Ber Dtsch Chem Ges 64:2844\u20132856. https:\/\/doi.org\/10.1002\/cber.19320650507","journal-title":"Ber Dtsch Chem Ges"},{"key":"1560_CR82","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.brainres.2011.02.041","volume":"1386","author":"Y Han","year":"2011","unstructured":"Han Y, Khodr CE, Sapru MK, Pedapati J, Bohn MC (2011) A microRNA embedded AAV alpha-synuclein gene silencing vector for dopaminergic neurons. Brain Res 1386:15\u201324. https:\/\/doi.org\/10.1016\/j.brainres.2011.02.041","journal-title":"Brain Res"},{"key":"1560_CR83","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40478-017-0494-9","volume":"5","author":"AS Harms","year":"2017","unstructured":"Harms AS, Delic V, Thome AD, Bryant N, Liu Z, Chandra S, Jurkuvenaite A, West AB (2017) \u03b1-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration. Acta Neuropathol Commun 5:85. https:\/\/doi.org\/10.1186\/s40478-017-0494-9","journal-title":"Acta Neuropathol Commun"},{"key":"1560_CR84","doi-asserted-by":"publisher","first-page":"23622","DOI":"10.1074\/jbc.M313784200","volume":"279","author":"M Hashimoto","year":"2004","unstructured":"Hashimoto M, Bar-On P, Ho G, Takenouchi T, Rockenstein E, Crews L, Masliah E (2004) \u03b2-synuclein regulates Akt activity in neuronal cells: A possible mechanism for neuroprotection in Parkinson\u2019s disease. J Biol Chem 279:23622\u201323629. https:\/\/doi.org\/10.1074\/jbc.M313784200","journal-title":"J Biol Chem"},{"key":"1560_CR85","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fnins.2019.00216","volume":"13","author":"BJD Hawk","year":"2019","unstructured":"Hawk BJD, Khounlo R, Shin YK (2019) Alpha-Synuclein continues to enhance SNARE-dependent vesicle docking at exorbitant concentrations. Front Neurosci 13:216. https:\/\/doi.org\/10.3389\/fnins.2019.00216","journal-title":"Front Neurosci"},{"key":"1560_CR86","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/biom12010142","volume":"12","author":"J Hayashi","year":"2022","unstructured":"Hayashi J, Carver JA (2022) \u03b2-Synuclein: An enigmatic protein with diverse functionality. Biomolecules 12:142. https:\/\/doi.org\/10.3390\/biom12010142","journal-title":"Biomolecules"},{"key":"1560_CR87","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B (2021) Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther 6:425. https:\/\/doi.org\/10.1038\/s41392-021-00828-5","journal-title":"Signal Transduct Target Ther"},{"key":"1560_CR88","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1093\/hmg\/ddt192","volume":"22","author":"ML Hebron","year":"2013","unstructured":"Hebron ML, Lonskaya I, Moussa CEH (2013) Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of \u03b1-synuclein in Parkinson\u2019s disease models. Hum Mol Genet 22:3315\u20133328. https:\/\/doi.org\/10.1093\/hmg\/ddt192","journal-title":"Hum Mol Genet"},{"key":"1560_CR89","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.omtn.2017.08.013","volume":"9","author":"C Helmschrodt","year":"2017","unstructured":"Helmschrodt C, H\u00f6bel S, Sch\u00f6niger S, Bauer A, Bonicelli J, Gringmuth M, Fietz SA, Aigner A, Richter A, Richter F (2017) Polyethylenimine nanoparticle-mediated siRNA delivery to reduce \u03b1-synuclein expression in a model of Parkinson\u2019s disease. Mol Ther Nucleic Acids 9:57\u201368. https:\/\/doi.org\/10.1016\/j.omtn.2017.08.013","journal-title":"Mol Ther Nucleic Acids"},{"key":"1560_CR90","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/mds.28714","volume":"36","author":"A Heras-Garvin","year":"2021","unstructured":"Heras-Garvin A, Refolo V, Schmidt C, Malfertheiner K, Wenning GK, Bradbury M, Stamler D, Stefanova N (2021) ATH434 reduces \u03b1-synuclein-related neurodegeneration in a murine model of multiple system atrophy. Mov Disord 36:2605\u20132614. https:\/\/doi.org\/10.1002\/mds.28714","journal-title":"Mov Disord"},{"key":"1560_CR91","doi-asserted-by":"publisher","first-page":"1250532","DOI":"10.3389\/fnins.2023.1250532","volume":"17","author":"K Hou","year":"2023","unstructured":"Hou K, Liu T, Li J, Xian M, Sun L, Wei J (2023) Liquid-liquid phase separation regulates alpha-synuclein aggregate and mitophagy in Parkinson\u2019s disease. Front Neurosci 17:1250532. https:\/\/doi.org\/10.3389\/fnins.2023.1250532","journal-title":"Front Neurosci"},{"key":"1560_CR92","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.nano.2018.01.020","volume":"14","author":"K Hu","year":"2018","unstructured":"Hu K, Chen X, Chen W, Zhang L, Li J, Ye J, Zhang Y, Zhang L, Li CH, Yin L, Guan YQ (2018) Neuroprotective effect of gold nanoparticles composites in Parkinson\u2019s disease model. Nanomedicine 14:1123\u20131136. https:\/\/doi.org\/10.1016\/j.nano.2018.01.020","journal-title":"Nanomedicine"},{"key":"1560_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068314","volume":"8","author":"YP Huang","year":"2013","unstructured":"Huang YP, Chen LS, Yen MF, Fann CY, Chiu YH, Chen HH, Pan SL (2013) Parkinson\u2019s disease is related to an increased risk of ischemic stroke\u2014a population-based propensity score-matched follow-up study. PLoS ONE 8:e68314. https:\/\/doi.org\/10.1371\/journal.pone.0068314","journal-title":"PLoS ONE"},{"key":"1560_CR94","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.neuroscience.2011.10.016","volume":"199","author":"Z Huang","year":"2011","unstructured":"Huang Z, Xu Z, Wu Y, Zhou Y (2011) Determining nuclear localization of alpha-synuclein in mouse brains. Neuroscience 199:318\u2013332. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.10.016","journal-title":"Neuroscience"},{"key":"1560_CR95","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","volume":"364","author":"P Ib\u00e1\u00f1ez","year":"2004","unstructured":"Ib\u00e1\u00f1ez P, Bonnet AM, D\u00e9barges B, Lohmann E, Tison F, Agid Y, Pollak P (2004) Causal relation between \u03b1-synuclein gene duplication and familial Parkinson\u2019s disease. Lancet 364:1169\u20131171. https:\/\/doi.org\/10.1016\/S0140-6736(04)17104-3","journal-title":"Lancet"},{"key":"1560_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019622","volume":"6","author":"E Israeli","year":"2011","unstructured":"Israeli E, Yakunin E, Zarbiv Y, Hacohen-Solovich A, Kisos H, Loeb V, Lichtenstein M, Ben-Gedalya T, Sabag O, Pikarsky E, Lorberboum-Galski H, Sharon R (2011) \u03b1-Synuclein expression selectively affects tumorigenesis in mice modeling Parkinson\u2019s disease. PLoS ONE 6:e19622. https:\/\/doi.org\/10.1371\/journal.pone.0019622","journal-title":"PLoS ONE"},{"key":"1560_CR97","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.ymthe.2019.08.010","volume":"27","author":"M Izco","year":"2019","unstructured":"Izco M, Blesa J, Schleef M, Schmeer M, Porcari R, Al-Shawi R, Ellmerich S, de Toro M, Gardiner C, Seow Y, Reinares-Sebastian A, Forcen R, Simons JP, Bellotti V, Cooper JM, Alvarez-Erviti L (2019) Systemic exosomal delivery of shRNA minicircles prevents Parkinsonian pathology. Mol Ther 27:2111\u20132122. https:\/\/doi.org\/10.1016\/j.ymthe.2019.08.010","journal-title":"Mol Ther"},{"key":"1560_CR98","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0014-5793(94)00395-5","volume":"345","author":"R Jakes","year":"1994","unstructured":"Jakes R, Spillantini MG, Goedert M (1994) Identification of two distinct synucleins from human brain. FEBS Lett 345:27\u201332. https:\/\/doi.org\/10.1016\/0014-5793(94)00395-5","journal-title":"FEBS Lett"},{"key":"1560_CR99","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","volume":"82","author":"JA Javitch","year":"1985","unstructured":"Javitch JA, D\u2019amato RJ, Strittmatter SM, Snyder SH (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82:2173\u20132177. https:\/\/doi.org\/10.1073\/pnas.82.7.2173","journal-title":"Proc Natl Acad Sci USA"},{"key":"1560_CR100","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/0014-2999(84)90740-4","volume":"106","author":"JA Javitch","year":"1985","unstructured":"Javitch JA, Snyder SH (1985) Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin. MPTP Eur J Pharmacol 106:455\u2013456. https:\/\/doi.org\/10.1016\/0014-2999(84)90740-4","journal-title":"MPTP Eur J Pharmacol"},{"key":"1560_CR101","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1111\/j.1742-4658.2011.08093.x","volume":"278","author":"PN Jethva","year":"2011","unstructured":"Jethva PN, Kardani JR, Roy I (2011) Modulation of \u03b1-synuclein aggregation by dopamine in the presence of MPTP and its metabolite. FEBS J 278:1688\u20131698. https:\/\/doi.org\/10.1111\/j.1742-4658.2011.08093.x","journal-title":"FEBS J"},{"key":"1560_CR102","first-page":"759","volume":"57","author":"H Ji","year":"1997","unstructured":"Ji H, Liu YE, Jia T, Wang M, Liu J, Xiao G, Joseph BK, Rosen C, Shi YE (1997) Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res 57:759\u2013764","journal-title":"Cancer Res"},{"key":"1560_CR103","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","volume":"30","author":"A Jowaed","year":"2010","unstructured":"Jowaed A, Schmitt I, Kaut O, W\u00fcllner U (2010) Methylation regulates alpha-synuclein expression and is decreased in Parkinson\u2019s disease patients\u2019 brains. J Neurosci 30:6355\u20136359. https:\/\/doi.org\/10.1523\/JNEUROSCI.6119-09.2010","journal-title":"J Neurosci"},{"key":"1560_CR104","doi-asserted-by":"publisher","first-page":"13052","DOI":"10.1073\/pnas.0906277106","volume":"106","author":"E Junn","year":"2009","unstructured":"Junn E, Lee KW, Seon JB, Chan TW, Im JY, Mouradian MM (2009) Repression of \u03b1-synuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci USA 106:13052\u201313057. https:\/\/doi.org\/10.1073\/pnas.0906277106","journal-title":"Proc Natl Acad Sci USA"},{"key":"1560_CR105","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0304-3940(02)00016-2","volume":"320","author":"E Junn","year":"2002","unstructured":"Junn E, Mouradian MM (2002) Human \u03b1-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine. Neurosci Lett 320:146\u2013150. https:\/\/doi.org\/10.1016\/S0304-3940(02)00016-2","journal-title":"Neurosci Lett"},{"key":"1560_CR106","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3233\/JAD-170601","volume":"61","author":"C Kaindlstorfer","year":"2018","unstructured":"Kaindlstorfer C, Jellinger KA, Eschlb\u00f6ck S, Stefanova N, Weiss G, Wenning GK (2018) The relevance of iron in the pathogenesis of multiple system atrophy: A viewpoint. Journal of Alzheimer\u2019s Disease 61:1253\u20131273. https:\/\/doi.org\/10.3233\/JAD-170601","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"1560_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.135769","author":"V Kakoty","year":"2021","unstructured":"Kakoty V, Kee S, Dubey SK, Yang CH, Kesharwani P, Taliyan R (2021) Lentiviral mediated gene delivery as an effective therapeutic approach for Parkinson disease. Neurosci Lett. https:\/\/doi.org\/10.1016\/j.neulet.2021.135769","journal-title":"Neurosci Lett"},{"key":"1560_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-2-6","author":"V Kallhoff","year":"2007","unstructured":"Kallhoff V, Peethumnongsin E, Zheng H (2007) Lack of \u03b1-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer\u2019s disease. Mol Neurodegener. https:\/\/doi.org\/10.1186\/1750-1326-2-6","journal-title":"Mol Neurodegener"},{"key":"1560_CR109","doi-asserted-by":"publisher","first-page":"9251","DOI":"10.1074\/jbc.M512292200","volume":"281","author":"F Kamp","year":"2006","unstructured":"Kamp F, Beyer K (2006) Binding of \u03b1-synuclein affects the lipid packing in bilayers of small vesicles. J Biol Chem 281:9251\u20139259. https:\/\/doi.org\/10.1074\/jbc.M512292200","journal-title":"J Biol Chem"},{"key":"1560_CR110","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.ymthe.2018.08.019","volume":"26","author":"B Kantor","year":"2018","unstructured":"Kantor B, Tagliafierro L, Gu J, Zamora ME, Ilich E, Grenier C, Huang ZY, Murphy S, Chiba-Falek O (2018) Downregulation of SNCA expression by targeted editing of DNA methylation: a potential strategy for precision therapy in PD. Mol Ther 26:2638\u20132649. https:\/\/doi.org\/10.1016\/j.ymthe.2018.08.019","journal-title":"Mol Ther"},{"key":"1560_CR111","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2022.01.007","volume":"101","author":"AA Karikari","year":"2022","unstructured":"Karikari AA, McFleder RL, Ribechini E, Blum R, Bruttel V, Knorr S, Gehmeyr M, Volkmann J, Brotchie JM, Ahsan F, Haack B, Monoranu CM, Keber U, Yeghiazaryan R, Pagenstecher A, Heckel T, Bischler T, Wischhusen J, Koprich JB, Lutz MB, Ip CW (2022) Neurodegeneration by \u03b1-synuclein-specific T cells in AAV-A53T-\u03b1-synuclein Parkinson\u2019s disease mice. Brain Behav Immun 101:194\u2013210. https:\/\/doi.org\/10.1016\/j.bbi.2022.01.007","journal-title":"Brain Behav Immun"},{"key":"1560_CR112","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/pl00007419","volume":"99","author":"M Kawashima","year":"2000","unstructured":"Kawashima M, Suzuki S, Doh-ura K (2000) \u03b1-Synuclein is expressed in a variety of brain tumors showing neuronal differentiation. Acta Neuropathol 99:154\u2013160. https:\/\/doi.org\/10.1007\/pl00007419","journal-title":"Acta Neuropathol"},{"key":"1560_CR113","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1093\/brain\/awab214","volume":"144","author":"A Khan","year":"2021","unstructured":"Khan A, Johnson R, Wittmer C, Maile M, Tatsukawa K, Wong JL, Gill MB, Stocking EM, Natala SR, Paulino AD, Bowden-Verhoek JK, Wrasidlo W, Masliah E, Bonhaus DW, Price DL (2021) NPT520-34 improves neuropathology and motor deficits in a transgenic mouse model of Parkinson\u2019s disease. Brain 144:3692\u20133709. https:\/\/doi.org\/10.1093\/brain\/awab214","journal-title":"Brain"},{"key":"1560_CR114","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.brainres.2011.04.036","volume":"1395","author":"CE Khodr","year":"2011","unstructured":"Khodr CE, Sapru MK, Pedapati J, Han Y, West NC, Kells AP, Bankiewicz KS, Bohn MC (2011) An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson\u2019s disease, but displays toxicity in dopamine neurons. Brain Res 1395:94\u2013107. https:\/\/doi.org\/10.1016\/j.brainres.2011.04.036","journal-title":"Brain Res"},{"key":"1560_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2534","author":"C Kim","year":"2013","unstructured":"Kim C, Ho DH, Suk JE, You S, Michael S, Kang J, Lee SJ, Masliah E, Hwang D, Lee HJ, Lee SJ (2013) Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun. https:\/\/doi.org\/10.1038\/ncomms2534","journal-title":"Nat Commun"},{"key":"1560_CR116","doi-asserted-by":"publisher","first-page":"7055","DOI":"10.1523\/JNEUROSCI.1241-16.2016","volume":"36","author":"TH Kim","year":"2016","unstructured":"Kim TH, Mehta SL, Kaimal B, Lyons K, Dempsey RJ, Vemuganti R (2016) Poststroke induction of \u03b1-synuclein mediates ischemic brain damage. J Neurosci 36:7055\u20137065. https:\/\/doi.org\/10.1523\/JNEUROSCI.1241-16.2016","journal-title":"J Neurosci"},{"key":"1560_CR117","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.59.4.609","author":"M Kinali","year":"2002","unstructured":"Kinali M, Mercuri E, Main M, De Biasia F, Karatza A, Higgins R, Banks L, Manzur A, Muntoni F (2002) Pilot trial of albuterol in spinal muscular atrophy. Neurology. https:\/\/doi.org\/10.1212\/wnl.59.4.609","journal-title":"Neurology"},{"key":"1560_CR118","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1016\/j.bpj.2008.12.3940","volume":"96","author":"L Kjaer","year":"2009","unstructured":"Kjaer L, Giehm L, Heimburg T, Otzen D (2009) The influence of vesicle size and composition on \u03b1-synuclein structure and stability. Biophys J 96:2857\u20132870. https:\/\/doi.org\/10.1016\/j.bpj.2008.12.3940","journal-title":"Biophys J"},{"key":"1560_CR119","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.nbd.2005.08.018","volume":"21","author":"P Klivenyi","year":"2006","unstructured":"Klivenyi P, Siwek D, Gardian G, Yang L, Starkov A, Cleren C, Ferrante RJ, Kowall NW, Abeliovich A, Beal MF (2006) Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiol Dis 21:541\u2013548. https:\/\/doi.org\/10.1016\/j.nbd.2005.08.018","journal-title":"Neurobiol Dis"},{"key":"1560_CR120","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.bbr.2012.03.026","volume":"231","author":"VS Kokhan","year":"2012","unstructured":"Kokhan VS, Afanasyeva MA, Van\u2019kin, G.I., (2012) \u03b1-Synuclein knockout mice have cognitive impairments. Behav Brain Res 231:226\u2013230. https:\/\/doi.org\/10.1016\/j.bbr.2012.03.026","journal-title":"Behav Brain Res"},{"key":"1560_CR121","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200001170-00041","author":"NW Kowall","year":"2000","unstructured":"Kowall NW, Hantraye P, Brouillet E, Beal MF, McKee AC, Ferrante RJ (2000) MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. Clin Neurosci Neuropathol. https:\/\/doi.org\/10.1097\/00001756-200001170-00041","journal-title":"Clin Neurosci Neuropathol"},{"key":"1560_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/ng0298-106","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger R, Kuhn W, M\u00fcller T et al (1998) Ala30Pro mutation in the gene encoding \u03b1-synuclein in Parkinson\u2019s disease. Nature. https:\/\/doi.org\/10.1038\/ng0298-106","journal-title":"Nature"},{"key":"1560_CR123","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn0044","author":"ST Kumar","year":"2022","unstructured":"Kumar ST, Mahul-Mellier A-L, Narayana Hegde R, Rivi\u00e8re G, Moons R, Ib\u00e1\u00f1ez de Opakua A, Magalh\u00e3es P, Rostami I, Donzelli S, Sobott F, Zweckstetter M, Lashuel HA (2022) A NAC domain mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein and recapitulates its pathological diversity. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abn0044","journal-title":"Sci Adv"},{"key":"1560_CR124","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1021\/acs.accounts.3c00386","volume":"56","author":"D Kurouski","year":"2023","unstructured":"Kurouski D (2023) Elucidating the role of lipids in the aggregation of amyloidogenic proteins. Acc Chem Res 56:2898\u20132906. https:\/\/doi.org\/10.1021\/acs.accounts.3c00386","journal-title":"Acc Chem Res"},{"key":"1560_CR125","doi-asserted-by":"publisher","first-page":"547","DOI":"10.5607\/en.2019.28.5.547","volume":"28","author":"S Kwon","year":"2019","unstructured":"Kwon S, Iba M, Masliah E, Kim C (2019) Targeting microglial and neuronal toll-like receptor 2 in synucleinopathies. Exp Neurobiol 28:547\u2013553. https:\/\/doi.org\/10.5607\/en.2019.28.5.547","journal-title":"Exp Neurobiol"},{"key":"1560_CR126","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979\u2013980. https:\/\/doi.org\/10.1126\/science.6823561","journal-title":"Science"},{"key":"1560_CR127","doi-asserted-by":"publisher","first-page":"10253","DOI":"10.1523\/JNEUROSCI.0581-12.2012","volume":"32","author":"ME Larson","year":"2012","unstructured":"Larson ME, Sherman MA, Greimel S, Kuskowski M, Schneider JA, Bennett DA, Lesn\u00e9 SE (2012) Soluble \u03b1-synuclein is a novel modulator of Alzheimer\u2019s disease pathophysiology. J Neurosci 32:10253\u201310266. https:\/\/doi.org\/10.1523\/JNEUROSCI.0581-12.2012","journal-title":"J Neurosci"},{"key":"1560_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03111-4","author":"J Lautenschl\u00e4ger","year":"2018","unstructured":"Lautenschl\u00e4ger J, Stephens AD, Fusco G, Str\u00f6hl F, Curry N, Zacharopoulou M, Michel CH, Laine R, Nespovitaya N, Fantham M, Pinotsi D, Zago W, Fraser P, Tandon A, St George-Hyslop P, Rees E, Phillips JJ, De Simone A, Kaminski CF, Schierle GSK (2018) C-terminal calcium binding of \u03b1-synuclein modulates synaptic vesicle interaction. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-018-03111-4","journal-title":"Nat Commun"},{"key":"1560_CR129","doi-asserted-by":"publisher","first-page":"615","DOI":"10.4049\/jimmunol.0903480","volume":"185","author":"E-J Lee","year":"2010","unstructured":"Lee E-J, Woo M-S, Moon P-G, Baek M-C, Choi I-Y, Kim W-K, Junn E, Kim H-S (2010) \u03b1-Synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1. J Immunol 185:615\u2013623. https:\/\/doi.org\/10.4049\/jimmunol.0903480","journal-title":"J Immunol"},{"key":"1560_CR130","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.23894","volume":"73","author":"S Lesage","year":"2013","unstructured":"Lesage S, Anheim M, Letournel F, Bousset L, Honor\u00e9 A, Rozas N, Pieri L, Madiona K, D\u00fcrr A, Melki R, Verny C, Brice A (2013) G51D \u03b1-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome. Ann Neurol 73:459\u2013471. https:\/\/doi.org\/10.1002\/ana.23894","journal-title":"Ann Neurol"},{"key":"1560_CR131","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1353-8020(11)70022-0","volume":"18","author":"S Lesage","year":"2012","unstructured":"Lesage S, Brice A (2012) Role of Mendelian genes in \u201csporadic\u201d Parkinson\u2019s disease. Parkinsonism Relat Disord 18:66\u201370. https:\/\/doi.org\/10.1016\/S1353-8020(11)70022-0","journal-title":"Parkinsonism Relat Disord"},{"key":"1560_CR132","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/s41380-023-02399-z","volume":"29","author":"S Levi","year":"2024","unstructured":"Levi S, Ripamonti M, Moro AS, Cozzi A (2024) Iron imbalance in neurodegeneration. Mol Psychiatry 29:1139\u20131152. https:\/\/doi.org\/10.1038\/s41380-023-02399-z","journal-title":"Mol Psychiatry"},{"key":"1560_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-3-19","author":"J Lewis","year":"2008","unstructured":"Lewis J, Melrose H, Bumcrot D, Hope A, Zehr C, Lincoln S, Braithwaite A, He Z, Ogholikhan S, Hinkle K, Kent C, Toudjarska I, Charisse K, Braich R, Pandey RK, Heckman M, Maraganore DM, Crook J, Farrer MJ (2008) In vivo silencing of alpha-synuclein using naked siRNA. Mol Neurodegener. https:\/\/doi.org\/10.1186\/1750-1326-3-19","journal-title":"Mol Neurodegener"},{"key":"1560_CR134","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-021-01203-9","author":"M Lin","year":"2021","unstructured":"Lin M, Mackie PM, Shaerzadeh F, Gamble-George J, Miller DR, Martyniuk CJ, Khoshbouei H (2021) In Parkinson\u2019s patient-derived dopamine neurons, the triplication of \u03b1-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/s40478-021-01203-9","journal-title":"Acta Neuropathol Commun"},{"key":"1560_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106010","author":"S Lin","year":"2023","unstructured":"Lin S, Leit\u00e3o ADG, Fang S, Gu Y, Barber S, Gilliard-Telefoni R, Castro A, Sung K, Shen R, Florio JB, Mante ML, Ding J, Spencer B, Masliah E, Rissman RA, Wu C (2023) Overexpression of alpha-synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2023.106010","journal-title":"Neurobiol Dis"},{"key":"1560_CR136","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/0092-8674(92)90425-C","volume":"70","author":"Y Liu","year":"1992","unstructured":"Liu Y, Peter D, Roghani A, Schuldiner S, Prive GG, Eisenberg D, Brecha N, Edwards RH (1992a) A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell 70:539\u2013551. https:\/\/doi.org\/10.1016\/0092-8674(92)90425-C","journal-title":"Cell"},{"key":"1560_CR137","doi-asserted-by":"publisher","first-page":"9074","DOI":"10.1073\/pnas.89.19.9074","volume":"89","author":"Y Liu","year":"1992","unstructured":"Liu Y, Roghani A, Edwards RH (1992b) Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium. Neurobiology 89:9074\u20139078. https:\/\/doi.org\/10.1073\/pnas.89.19.9074","journal-title":"Neurobiology"},{"key":"1560_CR138","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0165-0378(98)00009-6","volume":"38","author":"G Ljunggren","year":"1998","unstructured":"Ljunggren G, Anderson DJ (1998) Cytokine induced modulation of MHC class I and class II molecules on human cervical epithelial cells. J Reprod Immunol 38:124. https:\/\/doi.org\/10.1016\/S0165-0378(98)00009-6","journal-title":"J Reprod Immunol"},{"key":"1560_CR139","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01327-6","author":"S Lohmann","year":"2022","unstructured":"Lohmann S, Grigoletto J, Bernis ME, Pesch V, Ma L, Reithofer S, Tamg\u00fcney G (2022) Ischemic stroke causes Parkinson\u2019s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/s40478-022-01327-6","journal-title":"Acta Neuropathol Commun"},{"key":"1560_CR140","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00401-018-1829-8","volume":"135","author":"E Luna","year":"2018","unstructured":"Luna E, Decker SC, Riddle DM, Caputo A, Zhang B, Cole T, Caswell C, Xie SX, Lee VMY, Luk KC (2018) Differential \u03b1-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity. Acta Neuropathol 135:855\u2013875. https:\/\/doi.org\/10.1007\/s00401-018-1829-8","journal-title":"Acta Neuropathol"},{"key":"1560_CR141","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1073\/pnas.1200575109","volume":"109","author":"M Lundblad","year":"2012","unstructured":"Lundblad M, Decressac M, Mattsson B, Bj\u00f6rklund A (2012) Impaired neurotransmission caused by overexpression of \u03b1-synuclein in nigral dopamine neurons. Proc Natl Acad Sci USA 109:3213\u20133219. https:\/\/doi.org\/10.1073\/pnas.1200575109","journal-title":"Proc Natl Acad Sci USA"},{"key":"1560_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06251-8","author":"O Lurette","year":"2023","unstructured":"Lurette O, Mart\u00edn-Jim\u00e9nez R, Khan M, Sheta R, Jean S, Schofield M, Teixeira M, Rodriguez-Aller R, Perron I, Oueslati A, Hebert-Chatelain E (2023) Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induces mitophagy via cardiolipin externalization. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-023-06251-8","journal-title":"Cell Death Dis"},{"key":"1560_CR143","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1093\/hmg\/ddw185","volume":"25","author":"J Magalhaes","year":"2016","unstructured":"Magalhaes J, Gegg ME, Migdalska-Richards A, Doherty MK, Whitfield PD, Schapira AHV (2016) Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: Relevance to Parkinson disease. Hum Mol Genet 25:3432\u20133445. https:\/\/doi.org\/10.1093\/hmg\/ddw185","journal-title":"Hum Mol Genet"},{"key":"1560_CR144","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3233\/JPD-140503","volume":"5","author":"I Magen","year":"2015","unstructured":"Magen I, Torres ER, Dinh D, Chung A, Masliah E, Chesselet MF (2015) Social cognition impairments in mice overexpressing alpha-synuclein under the Thy1 promoter, a model of pre-manifest Parkinson\u2019s disease. J Parkinsons Dis 5:669\u2013680. https:\/\/doi.org\/10.3233\/JPD-140503","journal-title":"J Parkinsons Dis"},{"key":"1560_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.737195","author":"K Malfertheiner","year":"2021","unstructured":"Malfertheiner K, Stefanova N, Heras-Garvin A (2021) The concept of \u03b1-synuclein strains and how different conformations may explain distinct neurodegenerative disorders. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2021.737195","journal-title":"Front Neurol"},{"key":"1560_CR146","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","volume":"8","author":"L Maroteaux","year":"1988","unstructured":"Maroteaux L, Campanelli JT, Scheller RH (1988) Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804\u20132815. https:\/\/doi.org\/10.1523\/JNEUROSCI.08-08-02804.1988","journal-title":"J Neurosci"},{"key":"1560_CR147","doi-asserted-by":"publisher","first-page":"12245","DOI":"10.1073\/pnas.211412398","volume":"98","author":"E Masliah","year":"2001","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L (2001) \u03b2-Amyloid peptides enhance \u03b1-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer\u2019s disease and Parkinson\u2019s disease. Proc Natl Acad Sci USA 98:12245\u201312250. https:\/\/doi.org\/10.1073\/pnas.211412398","journal-title":"Proc Natl Acad Sci USA"},{"key":"1560_CR148","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.celrep.2019.01.015","volume":"26","author":"H Matsui","year":"2019","unstructured":"Matsui H, Kenmochi N, Namikawa K (2019) Age- and \u03b1-synuclein-dependent degeneration of dopamine and noradrenaline neurons in the annual killifish Nothobranchius furzeri. Cell Rep 26:1727-1733.e6. https:\/\/doi.org\/10.1016\/j.celrep.2019.01.015","journal-title":"Cell Rep"},{"key":"1560_CR149","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.neures.2009.07.010","volume":"65","author":"H Matsui","year":"2009","unstructured":"Matsui H, Taniguchi Y, Inoue H, Uemura K, Takeda S, Takahashi R (2009) A chemical neurotoxin, MPTP induces Parkinson\u2019s disease-like phenotype, movement disorders and persistent loss of dopamine neurons in medaka fish. Neurosci Res 65:263\u2013271. https:\/\/doi.org\/10.1016\/j.neures.2009.07.010","journal-title":"Neurosci Res"},{"key":"1560_CR150","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010481","author":"Y Matsuo","year":"2010","unstructured":"Matsuo Y, Kamitani T (2010) Parkinson\u2019s disease-related protein, \u03b1-synuclein, in malignant melanoma. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0010481","journal-title":"PLoS ONE"},{"key":"1560_CR151","doi-asserted-by":"publisher","unstructured":"Mayer RA, Kindt MV, Heikkila RE (1986) Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport. https:\/\/doi.org\/10.1111\/j.1471-4159.1986","DOI":"10.1111\/j.1471-4159.1986"},{"key":"1560_CR152","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0006-8993(02)03514-X","volume":"956","author":"GE Meredith","year":"2002","unstructured":"Meredith GE, Totterdell S, Petroske E, Santa Cruz K, Callison RC, Lau Y-S (2002) Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson\u2019s disease. Brain Res 956:156\u2013165. https:\/\/doi.org\/10.1016\/S0006-8993(02)03514-X","journal-title":"Brain Res"},{"key":"1560_CR153","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/mds.27723","volume":"34","author":"C Milanese","year":"2019","unstructured":"Milanese C, Pay\u00e1n-G\u00f3mez C, Galvani M, Gonz\u00e1lez NM, Tresini M, Abdellah SN, van Roon-Mom WMC, Figini S, Marinus J, van Hilten JJ, Mastroberardino PG (2019) Peripheral mitochondrial function correlates with clinical severity in idiopathic Parkinson\u2019s disease. Mov Disord 34:1192\u20131202. https:\/\/doi.org\/10.1002\/mds.27723","journal-title":"Mov Disord"},{"issue":"357","key":"1560_CR154","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1126\/science.aaf3934","volume":"1979","author":"S Mittal","year":"2017","unstructured":"Mittal S, Bj\u00f8rnevik K, Im DS, Flierl A, Dong X, Locascio JJ, Abo KM, Long E (2017) \u03b22-Adrenoreceptor is a regulator of the \u03b1-synuclein gene driving risk of Parkinson\u2019s disease. Science 1979(357):891\u2013898. https:\/\/doi.org\/10.1126\/science.aaf3934","journal-title":"Science"},{"key":"1560_CR155","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1111\/j.1471-4159.1987.tb05737.x","volume":"48","author":"Y Mizuno","year":"1987","unstructured":"Mizuno Y, Sone N, Saitoh T (1987) Effects of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine and 1-Methyl-4-Phenylpyridinium Ion on activities of the enzymes in the electron transport system in mouse brain. J Neurochem 48:1787\u20131793. https:\/\/doi.org\/10.1111\/j.1471-4159.1987.tb05737.x","journal-title":"J Neurochem"},{"key":"1560_CR156","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","volume":"165","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T (1994) Tumor necrosis factor-\u03b1 (TNF-\u03b1) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165:208\u2013210. https:\/\/doi.org\/10.1016\/0304-3940(94)90746-3","journal-title":"Neurosci Lett"},{"key":"1560_CR157","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","volume":"24","author":"HE Moon","year":"2015","unstructured":"Moon HE, Paek SH (2015) Mitochondrial dysfunction in Parkinson\u2019s disease. Exp Neurobiol 24:103\u2013116. https:\/\/doi.org\/10.5607\/en.2015.24.2.103","journal-title":"Exp Neurobiol"},{"key":"1560_CR158","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neuroscience.2012.11.023","volume":"232","author":"PK Multani","year":"2013","unstructured":"Multani PK, Hodge R, Est\u00e9vez MA, Abel T, Kung H, Alter M, Brookshire B, Lucki I, Nall AH, Talbot K, Doyle GA, Lohoff FW (2013) VMAT1 deletion causes neuronal loss in the hippocampus and neurocognitive deficits in spatial discrimination. Neuroscience 232:32\u201344. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.11.023","journal-title":"Neuroscience"},{"key":"1560_CR159","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuropharm.2006.03.004","volume":"51","author":"A Mu\u00f1oz","year":"2006","unstructured":"Mu\u00f1oz A, Rey P, Guerra MJ, Mendez-Alvarez E, Soto-Otero R, Labandeira-Garcia JL (2006) Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism. Neuropharmacology 51:112\u2013120. https:\/\/doi.org\/10.1016\/j.neuropharm.2006.03.004","journal-title":"Neuropharmacology"},{"key":"1560_CR160","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","volume":"20","author":"DD Murphy","year":"2000","unstructured":"Murphy DD, Rueter SM, Trojanowski JQ, Lee VM (2000) Synucleins are developmentally expressed, and \u03b1-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci 20:3214\u20133220. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-09-03214.2000","journal-title":"J Neurosci"},{"key":"1560_CR161","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bbrc.2007.04.108","volume":"358","author":"M Nakai","year":"2007","unstructured":"Nakai M, Fujita M, Waragai M, Sugama S, Wei J, Akatsu H, Ohtaka-Maruyama C, Okado H, Hashimoto M (2007) Expression of \u03b1-synuclein, a presynaptic protein implicated in Parkinson\u2019s disease, in erythropoietic lineage. Biochem Biophys Res Commun 358:104\u2013110. https:\/\/doi.org\/10.1016\/j.bbrc.2007.04.108","journal-title":"Biochem Biophys Res Commun"},{"key":"1560_CR162","doi-asserted-by":"publisher","first-page":"7479","DOI":"10.1523\/JNEUROSCI.0476-21.2021","volume":"41","author":"Y Nakamura","year":"2021","unstructured":"Nakamura Y, Arawaka S, Sato H, Sasaki A, Shigekiyo T, Takahata K, Tsunekawa H, Kato T (2021) Monoamine oxidase-B inhibition facilitates \u03b1-synuclein secretion in vitro and delays its aggregation in rAAV-based rat models of Parkinson\u2019s disease. J Neurosci 41:7479\u20137491. https:\/\/doi.org\/10.1523\/JNEUROSCI.0476-21.2021","journal-title":"J Neurosci"},{"key":"1560_CR163","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","volume":"65","author":"VM Nemani","year":"2010","unstructured":"Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, Lee MK, Chaudhry FA, Nicoll RA, Edwards RH (2010) Increased expression of \u03b1-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65:66\u201379. https:\/\/doi.org\/10.1016\/j.neuron.2009.12.023","journal-title":"Neuron"},{"key":"1560_CR164","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","volume":"36","author":"WJ Nicklas","year":"1985","unstructured":"Nicklas WJ, Vyas I, Heikkila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-Methyl-4-Phenyl-Pyridine, a metabolite of the neurotoxin, 1-Methyl-Phenyl-1,2,5,6-Tetrahydropyridine. Life Sci 36:2503\u20132508. https:\/\/doi.org\/10.1016\/0024-3205(85)90146-8","journal-title":"Life Sci"},{"key":"1560_CR165","doi-asserted-by":"publisher","DOI":"10.1038\/srep16615","author":"N Ninkina","year":"2015","unstructured":"Ninkina N, Connor-Robson N, Ustyugov AA, Tarasova TV, Shelkovnikova TA, Buchman VL (2015) A novel resource for studying function and dysfunction of \u03b1-synuclein: mouse lines for modulation of endogenous Snca gene expression. Sci Rep. https:\/\/doi.org\/10.1038\/srep16615","journal-title":"Sci Rep"},{"key":"1560_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101375","author":"N Ninkina","year":"2021","unstructured":"Ninkina N, Millership SJ, Peters OM, Connor-Robson N, Chaprov K, Kopylov AT, Montoya A, Kramer H, Withers DJ, Buchman VL (2021) \u03b2-Synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins. J Biol Chem. https:\/\/doi.org\/10.1016\/j.jbc.2021.101375","journal-title":"J Biol Chem"},{"key":"1560_CR167","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neurobiolaging.2020.02.026","volume":"91","author":"N Ninkina","year":"2020","unstructured":"Ninkina N, Tarasova TV, Chaprov KD, Roman AY, Kukharsky MS, Kolik LG, Ovchinnikov R, Ustyugov AA, Durnev AD, Buchman VL (2020) Alterations in the nigrostriatal system following conditional inactivation of \u03b1-synuclein in neurons of adult and aging mice. Neurobiol Aging 91:76\u201387. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.02.026","journal-title":"Neurobiol Aging"},{"key":"1560_CR168","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.parkreldis.2015.06.005","volume":"21","author":"S Olgiati","year":"2015","unstructured":"Olgiati S, Thomas A, Quadri M, Breedveld GJ, Graafland J, Eussen H, Douben H, de Klein A, Onofrj M, Bonifati V (2015) Early-onset parkinsonism caused by alpha-synuclein gene triplication: Clinical and genetic findings in a novel family. Parkinsonism Relat Disord 21:981\u2013986. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.06.005","journal-title":"Parkinsonism Relat Disord"},{"key":"1560_CR169","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.neuint.2004.03.029","volume":"45","author":"M Orth","year":"2004","unstructured":"Orth M, Tabrizi SJ, Tomlinson C, Messmer K, Korlipara LVP, Schapira AHV, Cooper JM (2004) G209A mutant alpha-synuclein expression specifically enhances dopamine-induced oxidative damage. Neurochem Int 45:669\u2013676. https:\/\/doi.org\/10.1016\/j.neuint.2004.03.029","journal-title":"Neurochem Int"},{"key":"1560_CR170","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.20338","volume":"57","author":"Y Ouchi","year":"2005","unstructured":"Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T (2005) Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease. Ann Neurol 57:168\u2013175. https:\/\/doi.org\/10.1002\/ana.20338","journal-title":"Ann Neurol"},{"key":"1560_CR171","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-9-18","author":"CR Overk","year":"2014","unstructured":"Overk CR, Cartier A, Shaked G, Rockenstein E, Ubhi K, Spencer B, Price DL, Patrick C, Desplats P, Masliah E (2014) Hippocampal neuronal cells that accumulate \u03b1-synuclein fragments are more vulnerable to A\u03b2 oligomer toxicity via mGluR5\u2014implications for dementia with Lewy bodies. Mol Neurodegener. https:\/\/doi.org\/10.1186\/1750-1326-9-18","journal-title":"Mol Neurodegener"},{"key":"1560_CR172","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071687","author":"M Pajares","year":"2020","unstructured":"Pajares M, Rojo I, Manda G, Bosc\u00e1 L, Cuadrado A (2020) Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications. Cells. https:\/\/doi.org\/10.3390\/cells9071687","journal-title":"Cells"},{"key":"1560_CR173","doi-asserted-by":"publisher","first-page":"16895","DOI":"10.1074\/JBC.M800747200","volume":"283","author":"KE Paleologou","year":"2008","unstructured":"Paleologou KE, Schmid AW, Rospigliosi CC, Kim HY, Lamberto GR, Fredenburg RA, Lansbury PT, Fernandez CO, Eliezer D, Zweckstetter M, Lashuel HA (2008) Phosphorylation at Ser-129 but not the phosphomimics S129E\/D inhibits the fibrillation of alpha-synuclein. J Biol Chem 283:16895\u201316905. https:\/\/doi.org\/10.1074\/JBC.M800747200","journal-title":"J Biol Chem"},{"key":"1560_CR174","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.1015881","author":"Y Pan","year":"2022","unstructured":"Pan Y, Zong Q, Li G, Wu Z, Du T, Huang Z, Zhang Y, Ma K (2022) Nuclear localization of alpha-synuclein affects the cognitive and motor behavior of mice by inducing DNA damage and abnormal cell cycle of hippocampal neurons. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2022.1015881","journal-title":"Front Mol Neurosci"},{"key":"1560_CR175","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00401-007-0332-4","volume":"115","author":"N Pandey","year":"2008","unstructured":"Pandey N, Strider J, Nolan WC, Yan SX, Galvin JE (2008) Curcumin inhibits aggregation of \u03b1-synuclein. Acta Neuropathol 115:479\u2013489. https:\/\/doi.org\/10.1007\/s00401-007-0332-4","journal-title":"Acta Neuropathol"},{"key":"1560_CR176","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ijbiomac.2022.03.092","volume":"209","author":"S Parsafar","year":"2022","unstructured":"Parsafar S, Aliakbari F, Seyedfatemi SS, Najarzadeh Z, Hourfar H, Bardania H, Farhadpour M, Mohammadi M, Morshedi D (2022) Insights into the inhibitory mechanism of skullcapflavone II against \u03b1-synuclein aggregation and its mediated cytotoxicity. Int J Biol Macromol 209:426\u2013440. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.03.092","journal-title":"Int J Biol Macromol"},{"key":"1560_CR177","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1161\/STROKEAHA.122.041239","volume":"54","author":"A Patrizz","year":"2023","unstructured":"Patrizz A, El Hamamy A, Maniskas M, Munshi Y, Atadja L, Ahnstedt H, Howe M, Bu F, Mulkey DK, McCullough LD, Li J (2023) Stroke-induced respiratory dysfunction is associated with cognitive decline. Stroke 54:1863\u20131874. https:\/\/doi.org\/10.1161\/STROKEAHA.122.041239","journal-title":"Stroke"},{"key":"1560_CR178","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/eji.201141915","volume":"42","author":"V Pattu","year":"2012","unstructured":"Pattu V, Qu B, Schwarz EC, Strau\u00df B, Weins L, Bhat SS, Halimani M, Marshall M, Rettig J, Hoth M (2012) SNARE protein expression and localization in human cytotoxic T lymphocytes. Eur J Immunol 42:470\u2013475. https:\/\/doi.org\/10.1002\/eji.201141915","journal-title":"Eur J Immunol"},{"key":"1560_CR179","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.neulet.2010.10.054","volume":"487","author":"A Pelkonen","year":"2011","unstructured":"Pelkonen A, Yavich L (2011) Neuromuscular pathology in mice lacking alpha-synuclein. Neurosci Lett 487:350\u2013353. https:\/\/doi.org\/10.1016\/j.neulet.2010.10.054","journal-title":"Neurosci Lett"},{"key":"1560_CR180","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fbioe.2020.588947","volume":"8","author":"S Pe\u00f1a-D\u00edaz","year":"2020","unstructured":"Pe\u00f1a-D\u00edaz S, Pujols J, Pinheiro F, Santos J, Pallar\u00e9s I, Navarro S, Conde-Gimenez M, Garc\u00eda J, Salvatella X, Dalf\u00f3 E, Sancho J, Ventura S (2020) Inhibition of \u03b1-synuclein aggregation and mature fibril disassembling with a minimalistic compound, ZPDm. Front Bioeng Biotechnol 8:8. https:\/\/doi.org\/10.3389\/fbioe.2020.588947","journal-title":"Front Bioeng Biotechnol"},{"key":"1560_CR181","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.284993","author":"S Pena-Diaz","year":"2020","unstructured":"Pena-Diaz S, Pujols J, Ventura S (2020) Small molecules to prevent the neurodegeneration caused by \u03b1-synuclein aggregation. Neural Regen Res. https:\/\/doi.org\/10.4103\/1673-5374.284993","journal-title":"Neural Regen Res"},{"key":"1560_CR182","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.819128","author":"Y Peng","year":"2022","unstructured":"Peng Y, Wang Y, Zhou C, Mei W, Zeng C (2022) PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: Are we making headway? Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2022.819128","journal-title":"Front Oncol"},{"key":"1560_CR183","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1523\/jneurosci.22-08-03090.2002","volume":"22","author":"RG Perez","year":"2002","unstructured":"Perez RG, Waymire JC, Lin E, Liu JJ, Guo F, Zigmond MJ (2002) A role for \u03b1-synuclein in the regulation of dopamine biosynthesis. J Neurosci 22:3090\u20133099. https:\/\/doi.org\/10.1523\/jneurosci.22-08-03090.2002","journal-title":"J Neurosci"},{"key":"1560_CR184","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1021\/acschembio.8b00466","volume":"13","author":"M Perni","year":"2018","unstructured":"Perni M, Flagmeier P, Limbocker R, Cascella R, Aprile FA, Galvagnion C, Heller GT, Meisl G, Chen SW, Kumita JR, Challa PK, Kirkegaard JB, Cohen SIA, Mannini B, Barbut D, Nollen EAA, Cecchi C, Cremades N, Knowles TPJ, Chiti F, Zasloff M, Vendruscolo M, Dobson CM (2018) Multistep inhibition of \u03b1-synuclein aggregation and toxicity in vitro and in vivo by trodusquemine. ACS Chem Biol 13:2308\u20132319. https:\/\/doi.org\/10.1021\/acschembio.8b00466","journal-title":"ACS Chem Biol"},{"key":"1560_CR185","doi-asserted-by":"publisher","first-page":"E1009","DOI":"10.1073\/pnas.1610586114","volume":"114","author":"M Perni","year":"2017","unstructured":"Perni M, Galvagnion C, Maltsev A, Meisl G, M\u00fcller MBD, Challa PK, Kirkegaard JB, Flagmeier P, Cohen SIA, Cascella R, Chen SW, Limboker R, Sormanni P, Heller GT, Aprile FA, Cremades N, Cecchi C, Chiti F, Nollen EAA, Knowles TPJ, Vendruscolo M, Bax A, Zasloff M, Dobson CM (2017) A natural product inhibits the initiation of \u03b1-synuclein aggregation and suppresses its toxicity. Proc Natl Acad Sci U S A 114:E1009\u2013E1017. https:\/\/doi.org\/10.1073\/pnas.1610586114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1560_CR186","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047. https:\/\/doi.org\/10.1126\/science.276.5321.2045","journal-title":"Science"},{"key":"1560_CR187","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s11064-014-1443-7","volume":"39","author":"J Prakash","year":"2014","unstructured":"Prakash J, Chouhan S, Yadav SK, Westfall S, Rai SN, Singh SP (2014) Withania somnifera alleviates Parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons. Neurochem Res 39:2527\u20132536. https:\/\/doi.org\/10.1007\/s11064-014-1443-7","journal-title":"Neurochem Res"},{"key":"1560_CR188","doi-asserted-by":"publisher","first-page":"10481","DOI":"10.1073\/pnas.1804198115","volume":"115","author":"J Pujols","year":"2018","unstructured":"Pujols J, Pe\u00f1a-D\u00edaz S, L\u00e1zaro DF, Peccati F, Pinheiro F, Gonz\u00e1lez D, Carija A, Navarro S, Conde-Gim\u00e9nez M, Garc\u00eda J, Guardiola S, Giralt E, Salvatella X, Sancho J, Sodupe M, Outeiro TF, Dalf\u00f3 E, Ventura S (2018) Small molecule inhibits \u03b1-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons. Proc Natl Acad Sci USA 115:10481\u201310486. https:\/\/doi.org\/10.1073\/pnas.1804198115","journal-title":"Proc Natl Acad Sci USA"},{"key":"1560_CR189","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.nbd.2005.05.028","volume":"20","author":"MG Purisai","year":"2005","unstructured":"Purisai MG, McCormack AL, Langston WJ, Johnston LC, Di Monte DA (2005) \u03b1-Synuclein expression in the substantia nigra of MPTP-lesioned non-human primates. Neurobiol Dis 20:898\u2013906. https:\/\/doi.org\/10.1016\/j.nbd.2005.05.028","journal-title":"Neurobiol Dis"},{"key":"1560_CR190","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6900","author":"A Quesnel","year":"2024","unstructured":"Quesnel A, Martin LD, Tarzi C, Lenis VP, Coles N, Islam M, Angione C, Outeiro TF, Khundakar AA, Filippou PS (2024) Uncovering potential diagnostic and pathophysiological roles of \u03b1-synuclein and DJ-1 in melanoma. Cancer Med. https:\/\/doi.org\/10.1002\/cam4.6900","journal-title":"Cancer Med"},{"key":"1560_CR191","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/jnen\/59.11.1067","volume":"59","author":"R Raghavan","year":"2000","unstructured":"Raghavan R, White CL III, Rogers B, Coimbra C, Rushing EJ (2000) Alpha-synuclein expression in central nervous system tumors showing neuronal or mixed neuronal\/glial differentiation. J Neuropathol Exp Neurol 59:1067\u20131072. https:\/\/doi.org\/10.1093\/jnen\/59.11.1067","journal-title":"J Neuropathol Exp Neurol"},{"key":"1560_CR192","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jchemneu.2015.12.002","volume":"71","author":"SN Rai","year":"2016","unstructured":"Rai SN, Yadav SK, Singh D, Singh SP (2016) Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model. J Chem Neuroanat 71:41\u201349. https:\/\/doi.org\/10.1016\/j.jchemneu.2015.12.002","journal-title":"J Chem Neuroanat"},{"key":"1560_CR193","doi-asserted-by":"publisher","DOI":"10.3390\/diseases11030089","author":"K Ramakrishna","year":"2023","unstructured":"Ramakrishna K, Nalla LV, Naresh D, Venkateswarlu K, Viswanadh MK, Nalluri BN, Chakravarthy G, Duguluri S, Singh P, Rai SN, Kumar A, Singh V, Singh SK (2023) WNT-\u03b2 catenin signaling as a potential therapeutic target for neurodegenerative diseases: current status and future perspective. Diseases. https:\/\/doi.org\/10.3390\/diseases11030089","journal-title":"Diseases"},{"key":"1560_CR194","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","volume":"10","author":"S Ramesh","year":"2023","unstructured":"Ramesh S, Arachchige ASPM (2023) Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: a review of the literature. AIMS Neurosci 10:200\u2013231. https:\/\/doi.org\/10.3934\/Neuroscience.2023017","journal-title":"AIMS Neurosci"},{"key":"1560_CR195","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2478\/intox-2014-0017","volume":"7","author":"MH Ratner","year":"2014","unstructured":"Ratner MH, Farb DH, Ozer J, Feldman RG, Durso R (2014) Younger age at onset of sporadic Parkinson\u2019s disease among subjects occupationally exposed to metals and pesticides. Interdiscip Toxicol 7:122\u2013133. https:\/\/doi.org\/10.2478\/intox-2014-0017","journal-title":"Interdiscip Toxicol"},{"key":"1560_CR196","doi-asserted-by":"publisher","first-page":"6686","DOI":"10.4049\/jimmunol.175.10.6686","volume":"175","author":"E Reales","year":"2005","unstructured":"Reales E, Mora-L\u00f3pez F, Rivas V, Garc\u00eda-Poley A, Brieva JA, Campos-Caro A (2005) Identification of soluble N-ethylmaleimide-sensitive factor attachment protein receptor exocytotic machinery in human plasma cells: SNAP-23 is essential for antibody secretion. J Immunol 175:6686\u20136693. https:\/\/doi.org\/10.4049\/jimmunol.175.10.6686","journal-title":"J Immunol"},{"key":"1560_CR197","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.166","author":"AK Reeve","year":"2015","unstructured":"Reeve AK, Ludtmann MHR, Angelova PR, Simcox EM, Horrocks MH, Klenerman D, Gandhi S, Turnbull DM, Abramov AY (2015) Aggregated \u03b1-synuclein and complex I deficiency: Exploration of their relationship in differentiated neurons. Cell Death Dis. https:\/\/doi.org\/10.1038\/cddis.2015.166","journal-title":"Cell Death Dis"},{"key":"1560_CR198","doi-asserted-by":"publisher","first-page":"8160","DOI":"10.1073\/pnas.84.22.8160","volume":"84","author":"JF Reinhard Jr","year":"1987","unstructured":"Reinhard JF Jr, Diliberto EJ Jr, Viveros OH, Daniels AJ (1987) Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells. Proc Natl Acad Sci USA 84:8160\u20138164. https:\/\/doi.org\/10.1073\/pnas.84.22.8160","journal-title":"Proc Natl Acad Sci USA"},{"key":"1560_CR199","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171925","author":"HL Roberts","year":"2017","unstructured":"Roberts HL, Schneider BL, Brown DR (2017) \u03b1-Synuclein increases \u03b2-amyloid secretion by promoting \u03b2-\/\u03b3-secretase processing of APP. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0171925","journal-title":"PLoS ONE"},{"key":"1560_CR200","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/j.1471-4159.2004.02378.x","volume":"89","author":"DC Robertson","year":"2004","unstructured":"Robertson DC, Schmidt O, Ninkina N, Jones PA, Sharkey J, Buchman VL (2004) Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of \u03b3-synuclein, \u03b1-synuclein and double \u03b1\/\u03b3-synuclein null mutant mice. J Neurochem 89:1126\u20131136. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02378.x","journal-title":"J Neurochem"},{"key":"1560_CR201","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1161\/01.STR.0000095188.65567.4F","volume":"34","author":"C Roffe","year":"2003","unstructured":"Roffe C, Sills S, Halim M, Wilde K, Allen MB, Jones PW, Crome P (2003) Unexpected nocturnal hypoxia in patients with acute stroke. Stroke 34:2641\u20132645. https:\/\/doi.org\/10.1161\/01.STR.0000095188.65567.4F","journal-title":"Stroke"},{"key":"1560_CR202","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11248-016-9995-8","volume":"26","author":"AY Roman","year":"2017","unstructured":"Roman AY, Limorenko G, Ustyugov AA, Tarasova TV, Lysikova EA, Buchman VL, Ninkina N (2017) Generation of mouse lines with conditionally or constitutively inactivated Snca gene and Rosa26-stop-lacZ reporter located in cis on the mouse chromosome 6. Transgenic Res 26:301\u2013307. https:\/\/doi.org\/10.1007\/s11248-016-9995-8","journal-title":"Transgenic Res"},{"key":"1560_CR203","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37561-2","author":"R Rosado-Ramos","year":"2023","unstructured":"Rosado-Ramos R, Po\u00e7as GM, Marques D, Foito A, Sevillano M, Lopes-da-Silva M, Gon\u00e7alves LG, Menezes R, Ottens M, Stewart D, Ib\u00e1\u00f1ez de Opakua A, Zweckstetter M, Seabra MC, Mendes CS, Outeiro TF, Domingos PM, Santos CN (2023) Genipin prevents alpha-synuclein aggregation and toxicity by affecting endocytosis, metabolism, and lipid storage. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-023-37561-2","journal-title":"Nat Commun"},{"key":"1560_CR204","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu13030986","volume":"13","author":"V Sambra","year":"2021","unstructured":"Sambra V, Echeverria F, Valenzuela A, Chouinard-Watkins R, Valenzuela R (2021) Docosahexaenoic and arachidonic acids as neuroprotective nutrients throughout the life cycle. Nutrients 13:1\u201321. https:\/\/doi.org\/10.3390\/nu13030986","journal-title":"Nutrients"},{"key":"1560_CR205","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.expneurol.2005.12.024","volume":"198","author":"MK Sapru","year":"2006","unstructured":"Sapru MK, Yates JW, Hogan S, Jiang L, Halter J, Bohn MC (2006) Silencing of human \u03b1-synuclein in vitro and in rat brain using lentiviral-mediated RNAi. Exp Neurol 198:382\u2013390","journal-title":"Exp Neurol"},{"key":"1560_CR206","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91116-3","author":"AD Sauerbeck","year":"2021","unstructured":"Sauerbeck AD, Goldstein EZ, Alfredo AN, Norenberg M, Marcillo A, McTigue DM (2021) Alpha-synuclein increases in rodent and human spinal cord injury and promotes inflammation and tissue loss. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-021-91116-3","journal-title":"Sci Rep"},{"key":"1560_CR207","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0306-4522(03)00036-8","volume":"118","author":"OM Schl\u00fcter","year":"2003","unstructured":"Schl\u00fcter OM, Fornai F, Alessandr\u00ed MG, Takamori S, Geppert M, Jahn R, S\u00fcdhof TC (2003) Role of \u03b1-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. Neuroscience 118:985\u20131002. https:\/\/doi.org\/10.1016\/S0306-4522(03)00036-8","journal-title":"Neuroscience"},{"key":"1560_CR208","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2022.102952","author":"Y Schneider","year":"2022","unstructured":"Schneider Y, Turan S, Koller A, Krumbiegel M, Farrell M, Pl\u00f6tz S, Winkler J, Xiang W (2022) Generation of a homozygous and a heterozygous SNCA gene knockout human-induced pluripotent stem cell line by CRISPR\/Cas9 mediated allele-specific tuning of SNCA expression. Stem Cell Res. https:\/\/doi.org\/10.1016\/j.scr.2022.102952","journal-title":"Stem Cell Res"},{"key":"1560_CR209","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","volume":"585","author":"M Schweighauser","year":"2020","unstructured":"Schweighauser M, Shi Y, Tarutani A, Kametani F, Murzin AG, Ghetti B, Matsubara T, Tomita T, Ando T, Hasegawa K, Murayama S, Yoshida M, Hasegawa M, Scheres SHW, Goedert M (2020) Structures of \u03b1-synuclein filaments from multiple system atrophy. Nature 585:464\u2013469. https:\/\/doi.org\/10.1038\/s41586-020-2317-6","journal-title":"Nature"},{"key":"1560_CR210","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/j.1460-9568.2008.06055.x","volume":"27","author":"SL Senior","year":"2008","unstructured":"Senior SL, Ninkina N, Deacon R, Bannerman D, Buchman VL, Cragg SJ, Wade-Martins R (2008) Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein. Eur J Neurosci 27:947\u2013957. https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06055.x","journal-title":"Eur J Neurosci"},{"key":"1560_CR211","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X, Hu B, Schmeichel A, Singer W, Wu G, Tsai AL, Shirani H, Nilsson KPR, Low PA, Soto C (2020) Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578:273\u2013277. https:\/\/doi.org\/10.1038\/s41586-020-1984-7","journal-title":"Nature"},{"key":"1560_CR212","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.imbio.2015.10.002","volume":"221","author":"A Shameli","year":"2016","unstructured":"Shameli A, Xiao W, Zheng Y, Shyu S, Sumodi J, Meyerson HJ, Harding CV, Maitta RW (2016) A critical role for alpha-synuclein in development and function of T lymphocytes. Immunobiology 221:333\u2013340. https:\/\/doi.org\/10.1016\/j.imbio.2015.10.002","journal-title":"Immunobiology"},{"key":"1560_CR213","doi-asserted-by":"publisher","DOI":"10.1016\/s0896-6273(03)00024-2","author":"R Sharon","year":"2003","unstructured":"Sharon R, Bar-Joseph I, Frosch MP, Walsh DM, Hamilton JA, Selkoe DJ (2003a) The formation of highly soluble oligomers of \u03b1-synuclein is regulated by fatty acids and enhanced in Parkinson\u2019s disease. Neuron. https:\/\/doi.org\/10.1016\/s0896-6273(03)00024-2","journal-title":"Neuron"},{"key":"1560_CR214","doi-asserted-by":"publisher","first-page":"49874","DOI":"10.1074\/jbc.M309127200","volume":"278","author":"R Sharon","year":"2003","unstructured":"Sharon R, Bar-Joseph I, Mirick GE, Serhan CN, Selkoe DJ (2003b) Altered fatty acid composition of dopaminergic neurons expressing \u03b1-synuclein and human brains with \u03b1-synucleinopathies. J Biol Chem 278:49874\u201349881. https:\/\/doi.org\/10.1074\/jbc.M309127200","journal-title":"J Biol Chem"},{"key":"1560_CR215","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84443-y","author":"S Shekoohi","year":"2021","unstructured":"Shekoohi S, Rajasekaran S, Patel D, Yang S, Liu W, Huang S, Yu X, Witt SN (2021) Knocking out alpha-synuclein in melanoma cells dysregulates cellular iron metabolism and suppresses tumor growth. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-021-84443-y","journal-title":"Sci Rep"},{"key":"1560_CR216","doi-asserted-by":"publisher","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","volume":"23","author":"TB Sherer","year":"2003","unstructured":"Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT (2003) Mechanism of toxicity in rotenone models of Parkinson\u2019s disease. J Neurosci 23:10756\u201310764. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-34-10756.2003","journal-title":"J Neurosci"},{"issue":"1","key":"1560_CR217","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10059-000-0065-x","volume":"10","author":"EC Shin","year":"1999","unstructured":"Shin EC, Cho SE, Lee DK, Hurl MW, Paik SR, Park JH, Kim J (1999) Expression patterns of \u03b1-synuclein in human hematopoietic cells and in Drosophila at different developmental stages. Mol Cells 10(1):65\u201370. https:\/\/doi.org\/10.1007\/s10059-000-0065-x","journal-title":"Mol Cells"},{"key":"1560_CR218","doi-asserted-by":"publisher","first-page":"18957","DOI":"10.1074\/jbc.M113.527341","volume":"289","author":"N Shioda","year":"2014","unstructured":"Shioda N, Yabuki Y, Kobayashi Y, Onozato M, Owada Y, Fukunaga K (2014) FABP3 protein promotes \u03b1-synuclein oligomerization associated with 1-methyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Biol Chem 289:18957\u201318965. https:\/\/doi.org\/10.1074\/jbc.M113.527341","journal-title":"J Biol Chem"},{"key":"1560_CR219","doi-asserted-by":"publisher","first-page":"7971","DOI":"10.1523\/JNEUROSCI.0775-16.2016","volume":"36","author":"B Spencer","year":"2016","unstructured":"Spencer B, Desplats PA, Overk CR, Valera-Martin E, Rissman RA, Wu C, Mante M, Adame A, Florio J, Rockenstein E, Masliah E (2016) Reducing endogenous \u03b1-synuclein mitigates the degeneration of selective neuronal populations in an Alzheimer\u2019s disease transgenic mouse model. J Neurosci 36:7971\u20137984. https:\/\/doi.org\/10.1523\/JNEUROSCI.0775-16.2016","journal-title":"J Neurosci"},{"key":"1560_CR220","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.nbd.2019.03.001","volume":"127","author":"B Spencer","year":"2019","unstructured":"Spencer B, Trinh I, Rockenstein E, Mante M, Florio J, Adame A, El-Agnaf OMA, Kim C, Masliah E, Rissman RA (2019) Systemic peptide mediated delivery of an siRNA targeting \u03b1-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease. Neurobiol Dis 127:163\u2013177. https:\/\/doi.org\/10.1016\/j.nbd.2019.03.001","journal-title":"Neurobiol Dis"},{"key":"1560_CR221","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-015-0043-6","author":"B Spencer","year":"2015","unstructured":"Spencer B, Valera E, Rockenstein E, Trejo-Morales M, Adame A, Masliah E (2015) A brain-targeted, modified neurosin (kallikrein-6) reduces \u03b1-synuclein accumulation in a mouse model of multiple system atrophy. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-015-0043-6","journal-title":"Mol Neurodegener"},{"key":"1560_CR222","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"M Spillantini","year":"1997","unstructured":"Spillantini M, Schmidt M, Lee V, Charlesworth B (1997) \u03b1-Synuclein in Lewy bodies. Nature 388:839\u2013840. https:\/\/doi.org\/10.1038\/42166","journal-title":"Nature"},{"key":"1560_CR223","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128510","author":"KJ Spinelli","year":"2015","unstructured":"Spinelli KJ, Osterberg VR, Meshul CK, Soumyanath A, Unni VK (2015) Curcumin treatment improves motor behavior in \u03b1-synuclein transgenic mice. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0128510","journal-title":"PLoS ONE"},{"key":"1560_CR224","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/jnc.14810","volume":"150","author":"D Sulzer","year":"2019","unstructured":"Sulzer D, Edwards RH (2019) The physiological role of \u03b1-synuclein and its relationship to Parkinson\u2019s disease. J Neurochem 150:475\u2013486. https:\/\/doi.org\/10.1111\/jnc.14810","journal-title":"J Neurochem"},{"key":"1560_CR225","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2023.102084","author":"Z Sun","year":"2024","unstructured":"Sun Z, Kantor B, Chiba-Falek O (2024) Neuronal-type-specific epigenome editing to decrease SNCA expression: implications for precision medicine in synucleinopathies. Mol Ther Nucleic Acids. https:\/\/doi.org\/10.1016\/j.omtn.2023.102084","journal-title":"Mol Ther Nucleic Acids"},{"key":"1560_CR226","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1600-0773.1997.tb00051.x","volume":"81","author":"E Sundstr\u00f6m","year":"1997","unstructured":"Sundstr\u00f6m E, Samuelsson EB (1997) Comparison of key steps in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in rodents. Pharmacol Toxicol 81:226\u2013231. https:\/\/doi.org\/10.1111\/j.1600-0773.1997.tb00051.x","journal-title":"Pharmacol Toxicol"},{"key":"1560_CR227","first-page":"1540","volume":"14","author":"I Surgucheva","year":"2008","unstructured":"Surgucheva I, Weisman AD, Goldberg JL, Shnyra A, Surguchov A (2008) \u03b3-Synuclein as a marker of retinal ganglion cells. Mol vis 14:1540\u20131548","journal-title":"Mol vis"},{"key":"1560_CR228","doi-asserted-by":"publisher","first-page":"43933","DOI":"10.1074\/jbc.M111.241232","volume":"286","author":"J Swant","year":"2011","unstructured":"Swant J, Goodwin JS, North A, Ali AA, Gamble-George J, Chirwa S, Khoshbouei H (2011) \u03b1-synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter. J Biol Chem 286:43933\u201343943. https:\/\/doi.org\/10.1074\/jbc.M111.241232","journal-title":"J Biol Chem"},{"key":"1560_CR229","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bcmd.2018.09.001","volume":"73","author":"H Tashkandi","year":"2018","unstructured":"Tashkandi H, Shameli A, Harding CV, Maitta RW (2018) Ultrastructural changes in peripheral blood leukocytes in \u03b1-synuclein knockout mice. Blood Cells Mol Dis 73:33\u201337. https:\/\/doi.org\/10.1016\/j.bcmd.2018.09.001","journal-title":"Blood Cells Mol Dis"},{"key":"1560_CR230","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","volume":"67","author":"S Theodore","year":"2008","unstructured":"Theodore S, Cao S, Mclean PJ, Standaert DG (2008) Targeted overexpression of human \u03b1-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson\u2019s disease. J Neuropathol Exp Neurol 67:1149\u20131158. https:\/\/doi.org\/10.1097\/NEN.0b013e31818e5e99","journal-title":"J Neuropathol Exp Neurol"},{"key":"1560_CR231","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016706","author":"B Thomas","year":"2011","unstructured":"Thomas B, Mandir AS, West N, Liu Y, Andrabi SA, Stirling W, Dawson VL, Dawson TM, Lee MK (2011) Resistance to MPTP neurotoxicity in \u03b1-synuclein knockout mice is complemented by human \u03b1-synuclein and associated with increased \u03b2-synuclein and Akt activation. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0016706","journal-title":"PLoS ONE"},{"key":"1560_CR232","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev-nutr-082117-051732","volume":"38","author":"SV Torti","year":"2018","unstructured":"Torti SV, Manz DH, Paul BT, Blanchette-Farra N, Torti FM (2018) Iron and cancer. Annu Rev Nutr 38:97\u2013125. https:\/\/doi.org\/10.1146\/annurev-nutr-082117-051732","journal-title":"Annu Rev Nutr"},{"key":"1560_CR233","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003135","author":"IF Tsigelny","year":"2008","unstructured":"Tsigelny IF, Crews L, Desplats P, Shaked GM, Sharikov Y, Mizuno H, Spencer B, Rockenstein E, Trejo M, Platoshyn O, Yuan JXJ, Masliah E (2008) Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer\u2019s and Parkinson\u2019s diseases. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0003135","journal-title":"PLoS ONE"},{"key":"1560_CR234","doi-asserted-by":"publisher","unstructured":"Tsujiuchi T, Miller AD, Wakabayashi T, Natsume A (2013) RNA interference therapeutics for tumor therapy: promising work in progress. In: Gene therapy of cancer: translational approaches from preclinical studies to clinical implementation, 2nd edn, pp 393\u2013408. https:\/\/doi.org\/10.1016\/B978-0-12-394295-1.00027-5","DOI":"10.1016\/B978-0-12-394295-1.00027-5"},{"key":"1560_CR235","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43772-9","author":"T Uehara","year":"2019","unstructured":"Uehara T, Choong CJ, Nakamori M, Hayakawa H, Nishiyama K, Kasahara Y, Baba K, Nagata T, Yokota T, Tsuda H, Obika S, Mochizuki H (2019) Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting \u03b1-synuclein as a novel therapy for Parkinson\u2019s disease. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-019-43772-9","journal-title":"Sci Rep"},{"key":"1560_CR236","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jmb","volume":"389","author":"K Vamvaca","year":"2009","unstructured":"Vamvaca K, Volles MJ, Lansbury PT (2009) The first N-terminal amino acids of \u03b1-synuclein are essential for \u03b1-helical structure formation in vitro and membrane binding in yeast. J Mol Biol 389:413\u2013424. https:\/\/doi.org\/10.1016\/j.jmb","journal-title":"J Mol Biol"},{"key":"1560_CR237","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/(SICI)1097-4598(199609)19:9<1127::AID-MUS7>3.0.CO;2-1","volume":"19","author":"JG Van Dijk","year":"1996","unstructured":"Van Dijk JG, Lammers GJ, Wintzen AR, Molenaar PC (1996) Repetitive CMAPs: mechanisms of neural and synaptic genesis. Muscle Nerve 19:1127\u20131133. https:\/\/doi.org\/10.1002\/(SICI)1097-4598(199609)19:9%3c1127::AID-MUS7%3e3.0.CO;2-1","journal-title":"Muscle Nerve"},{"key":"1560_CR238","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.829291","author":"M Vendruscolo","year":"2022","unstructured":"Vendruscolo M (2022) Lipid homeostasis and its links with protein misfolding diseases. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2022.829291","journal-title":"Front Mol Neurosci"},{"key":"1560_CR239","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","volume":"74","author":"M Vila","year":"2000","unstructured":"Vila M, Vukosavic S, Jackson-Lewis V, Neystat M, Jakowec M, Przedborski S (2000) \u03b1-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J Neurochem 74:721\u2013729. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.740721.x","journal-title":"J Neurochem"},{"key":"1560_CR240","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neulet.2004.01.044","volume":"359","author":"DS Wang","year":"2004","unstructured":"Wang DS, Bennett DA, Mufson E, Cochran E, Dickson DW (2004) Decreases in soluble \u03b1-synuclein in frontal cortex correlate with cognitive decline in the elderly. Neurosci Lett 359:104\u2013108. https:\/\/doi.org\/10.1016\/j.neulet.2004.01.044","journal-title":"Neurosci Lett"},{"key":"1560_CR241","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41401-022-01039-6","volume":"44","author":"Q Wang","year":"2023","unstructured":"Wang Q, Yao S, Yang ZX, Zhou C, Zhang Y, Zhang Y, Zhang L, Li JT, Xu ZJ, Zhu WL, Zhang NX, Ye Y, Feng LY (2023) Pharmacological characterization of the small molecule 03A10 as an inhibitor of \u03b1-synuclein aggregation for Parkinson\u2019s disease treatment. Acta Pharmacol Sin 44:1122\u20131134. https:\/\/doi.org\/10.1038\/s41401-022-01039-6","journal-title":"Acta Pharmacol Sin"},{"key":"1560_CR242","doi-asserted-by":"publisher","first-page":"7031","DOI":"10.1523\/JNEUROSCI.0396-22.2022","volume":"42","author":"S Wang","year":"2022","unstructured":"Wang S, Fu Y, Miyata T, Matsumoto S, Shinoda T, Itoh K, Harada A, Hirotsune S, Jin M (2022) Functional cooperation of \u03b1-synuclein and tau is essential for proper corticogenesis. J Neurosci 42:7031\u20137046. https:\/\/doi.org\/10.1523\/JNEUROSCI.0396-22.2022","journal-title":"J Neurosci"},{"key":"1560_CR243","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.biopha.2015.08.025","volume":"74","author":"ZH Wang","year":"2015","unstructured":"Wang ZH, Zhang JL, Duan YL, Zhang QS, Li GF, Zheng DL (2015) MicroRNA-214 participates in the neuroprotective effect of resveratrol via inhibiting \u03b1-synuclein expression in MPTP-induced Parkinson\u2019s disease mouse. Biomed Pharmacother 74:252\u2013256. https:\/\/doi.org\/10.1016\/j.biopha.2015.08.025","journal-title":"Biomed Pharmacother"},{"key":"1560_CR244","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/WNL.0000000000008924","volume":"94","author":"R Waziry","year":"2020","unstructured":"Waziry R, Chibnik LB, Bos D, Ikram MK, Hofman A (2020) Risk of hemorrhagic and ischemic stroke in patients with Alzheimer disease. Neurology 94:265\u2013272. https:\/\/doi.org\/10.1212\/WNL.0000000000008924","journal-title":"Neurology"},{"key":"1560_CR245","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024588","author":"AL Woerman","year":"2018","unstructured":"Woerman AL, Watts JC, Aoyagi A, Giles K, Middleton LT, Prusiner SB (2018) \u03b1-synuclein: multiple system atrophy prions. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a024588","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1560_CR246","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/s41417-022-00425-w","volume":"29","author":"Z Wu","year":"2022","unstructured":"Wu Z, Xia C, Zhang C (2022) Adeno-associated virus-delivered alpha-synuclein inhibits bladder cancer growth via the p53\/p21 signaling pathway. Cancer Gene Ther 29:1193\u20131206. https:\/\/doi.org\/10.1038\/s41417-022-00425-w","journal-title":"Cancer Gene Ther"},{"key":"1560_CR247","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202200216","volume":"23","author":"B Xu","year":"2022","unstructured":"Xu B, Mo X, Chen J, Yu H, Liu Y (2022) Myricetin inhibits \u03b1-synuclein amyloid aggregation by delaying the liquid-to-solid phase transition. ChemBioChem 23:e202200216. https:\/\/doi.org\/10.1002\/cbic.202200216","journal-title":"ChemBioChem"},{"key":"1560_CR248","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.690496","volume":"12","author":"Y Xu","year":"2021","unstructured":"Xu Y, Kong X, Li J, Cui T, Wei Y, Xu J, Zhu Y, Zhu X (2021) Mild hypoxia enhances the expression of HIF and VEGF and triggers the response to injury in rat kidneys. Front Physiol 12:690496. https:\/\/doi.org\/10.3389\/fphys.2021.690496","journal-title":"Front Physiol"},{"key":"1560_CR249","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1007\/s11064-016-1995-9","volume":"41","author":"Y Xu","year":"2016","unstructured":"Xu Y, Zhang Y, Quan Z, Wong W, Guo J, Zhang R, Yang Q, Dai R, McGeer PL, Qing H (2016) Epigallocatechin gallate (EGCG) inhibits alpha-synuclein aggregation: a potential agent for Parkinson\u2019s disease. Neurochem Res 41:2788\u20132796. https:\/\/doi.org\/10.1007\/s11064-016-1995-9","journal-title":"Neurochem Res"},{"key":"1560_CR250","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchemneu.2016.11.009","volume":"80","author":"SK Yadav","year":"2017","unstructured":"Yadav SK, Rai SN, Singh SP (2017) Mucuna pruriens reduces inducible nitric oxide synthase expression in Parkinsonian mice model. J Chem Neuroanat 80:1\u201310. https:\/\/doi.org\/10.1016\/j.jchemneu.2016.11.009","journal-title":"J Chem Neuroanat"},{"key":"1560_CR251","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/genes9010016","volume":"9","author":"Y Yan","year":"2018","unstructured":"Yan Y, Xu Z, Hu X, Qian L, Li Z, Zhou Y, Dai S, Zeng S, Gong Z (2018) SNCA is a functionally low-expressed gene in lung adenocarcinoma. Genes (Basel) 9:16. https:\/\/doi.org\/10.3390\/genes9010016","journal-title":"Genes (Basel)"},{"key":"1560_CR252","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105218","volume":"148","author":"J Yang","year":"2021","unstructured":"Yang J, Luo S, Zhang J, Yu T, Fu Z, Zheng Y, Xu X, Liu C, Fan M, Zhang Z (2021) Exosome-mediated delivery of antisense oligonucleotides targeting \u03b1-synuclein ameliorates the pathology in a mouse model of Parkinson\u2019s disease. Neurobiol Dis 148:105218. https:\/\/doi.org\/10.1016\/j.nbd.2020.105218","journal-title":"Neurobiol Dis"},{"key":"1560_CR253","doi-asserted-by":"publisher","first-page":"11165","DOI":"10.1523\/JNEUROSCI.2559-04.2004","volume":"24","author":"L Yavich","year":"2004","unstructured":"Yavich L, Tanila H, Veps\u00e4l\u00e4inen S, J\u00e4k\u00e4l\u00e4 P (2004) Role of \u03b1-synuclein in presynaptic dopamine recruitment. J Neurosci 24:11165\u201311170. https:\/\/doi.org\/10.1523\/JNEUROSCI.2559-04.2004","journal-title":"J Neurosci"},{"key":"1560_CR254","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fnagi.2020.00060","volume":"12","author":"Q Ye","year":"2020","unstructured":"Ye Q, Wen Y, Al-Kuwari N, Chen X (2020) Association between Parkinson\u2019s disease and melanoma: putting the pieces together. Front Aging Neurosci 12:60. https:\/\/doi.org\/10.3389\/fnagi.2020.00060","journal-title":"Front Aging Neurosci"},{"key":"1560_CR255","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/sc.2016.74","volume":"54","author":"TS Yeh","year":"2016","unstructured":"Yeh TS, Huang YP, Wang HI, Pan SL (2016) Spinal cord injury and Parkinson\u2019s disease: a population-based, propensity score-matched, longitudinal follow-up study. Spinal Cord 54:1215\u20131219. https:\/\/doi.org\/10.1038\/sc.2016.74","journal-title":"Spinal Cord"},{"key":"1560_CR256","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1089\/crispr.2021.0025","volume":"5","author":"HH Yoon","year":"2022","unstructured":"Yoon HH, Ye S, Lim S, Lee SE, Oh S-J, Jo A, Lee H, Kim N-R, Kim K, Kim B-J, Lee CJ, Nam M-H, Hur JW, Jeon SR (2022) CRISPR-Cas9 gene editing protects from the A53T-SNCA overexpression-induced pathology of Parkinson\u2019s disease in vivo. CRISPR J 5:95\u2013108. https:\/\/doi.org\/10.1089\/crispr.2021.0025","journal-title":"CRISPR J"},{"key":"1560_CR257","first-page":"263","volume":"56","author":"S Yu","year":"2004","unstructured":"Yu S, Liu XM, Li YH, Lu GW, Chen B (2004) Effect of repeated acute hypoxic treatment on the expression of alpha-synuclein in the mouse brain cortex. Sheng Li Xue Bao 56:263\u2013268","journal-title":"Sheng Li Xue Bao"},{"key":"1560_CR258","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, G\u00f3mez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atar\u00e9s B, Llorens V, Gomez Tortosa E, Del Ser T, Mu\u00f1oz DG, De Yebenes JG (2004) The new mutation, E46K, of \u03b1-synuclein causes parkinson and lewy body dementia. Ann Neurol 55:164\u2013173. https:\/\/doi.org\/10.1002\/ana.10795","journal-title":"Ann Neurol"},{"key":"1560_CR259","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12974-019-1658-2","volume":"16","author":"H Zeng","year":"2019","unstructured":"Zeng H, Liu N, Yang YY, Xing HY, Liu XX, Li F, La GY, Huang MJ, Zhou MW (2019) Lentivirus-mediated downregulation of \u03b1-synuclein reduces neuroinflammation and promotes functional recovery in rats with spinal cord injury. J Neuroinflammation 16:283. https:\/\/doi.org\/10.1186\/s12974-019-1658-2","journal-title":"J Neuroinflammation"},{"key":"1560_CR260","doi-asserted-by":"publisher","first-page":"11111","DOI":"10.18632\/aging.103675","volume":"12","author":"H Zeng","year":"2020","unstructured":"Zeng H, Liu N, Liu XX, Yang YY, Zhou MW (2020) \u03b1-Synuclein in traumatic and vascular diseases of the central nervous system. Aging (Albany NY) 12:11111\u201311126. https:\/\/doi.org\/10.18632\/aging.103675","journal-title":"Aging (Albany NY)"},{"key":"1560_CR261","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fnins.2019.00381","volume":"13","author":"J Zhang","year":"2019","unstructured":"Zhang J, Li X, Li JD (2019) The roles of post-translational modifications on \u03b1-synuclein in the pathogenesis of Parkinson\u2019s diseases. Front Neurosci 13:381. https:\/\/doi.org\/10.3389\/fnins.2019.00381","journal-title":"Front Neurosci"},{"key":"1560_CR262","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1073\/pnas.1905057117","volume":"117","author":"P Zhang","year":"2020","unstructured":"Zhang P, Park H-J, Zhang J, Junn E, Andrews RJ, Pradeep Velagapudi S, Abegg D, Vishnu K, Costales MG, Childs-Disney JL, Adibekian A, Moss WN, Maral Mouradian M, Disney MD, Carver RJ (2020) Translation of the intrinsically disordered protein \u03b1-synuclein is inhibited by a small molecule targeting its structured mRNA. PNAS 117:1457\u20131467. https:\/\/doi.org\/10.1073\/pnas.1905057117","journal-title":"PNAS"},{"key":"1560_CR263","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhang W, Zhou Y, Hong J-S, Zhang J (2005) Aggregated \u03b1-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. FASEB J 19:533\u2013542. https:\/\/doi.org\/10.1096\/fj.04-2751com","journal-title":"FASEB J"},{"key":"1560_CR264","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s12885-022-09289-7","volume":"22","author":"X Zhang","year":"2022","unstructured":"Zhang X, Wu Z, Ma K (2022) SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma. BMC Cancer 22:406. https:\/\/doi.org\/10.1186\/s12885-022-09289-7","journal-title":"BMC Cancer"},{"key":"1560_CR265","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10072-016-2485-1","volume":"37","author":"HQ Zhao","year":"2016","unstructured":"Zhao HQ, Li FF, Wang Z, Wang XM, Feng T (2016) A comparative study of the amount of \u03b1-synuclein in ischemic stroke and Parkinson\u2019s disease. Neurol Sci 37:749\u2013754. https:\/\/doi.org\/10.1007\/s10072-016-2485-1","journal-title":"Neurol Sci"},{"key":"1560_CR266","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.nbd.2019.01.004","volume":"125","author":"A Zharikov","year":"2019","unstructured":"Zharikov A, Bai Q, De Miranda BR, Van Laar A, Greenamyre JT, Burton EA (2019) Long-term RNAi knockdown of \u03b1-synuclein in the adult rat substantia nigra without neurodegeneration. Neurobiol Dis 125:146\u2013153. https:\/\/doi.org\/10.1016\/j.nbd.2019.01.004","journal-title":"Neurobiol Dis"},{"key":"1560_CR267","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1172\/JCI64502","volume":"125","author":"A Zharikov","year":"2015","unstructured":"Zharikov A, Cannon JR, Tapias V, Bai Q, Horowitz MP, Shah V, El Ayadi A, Hastings TG, Greenamyre JT, Burton EA (2015) ShRNA targeting \u03b1-synuclein prevents neurodegeneration in a Parkinson\u2019s disease model. J Clin Investig 125:2721\u20132735. https:\/\/doi.org\/10.1172\/JCI64502","journal-title":"J Clin Investig"},{"key":"1560_CR268","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1017\/cjn.2016.261","volume":"43","author":"L Zhou","year":"2016","unstructured":"Zhou L, Jiang Y, Zhu C, Ma L, Huang Q, Chen X (2016) Oxidative stress and environmental exposures are associated with multiple system atrophy in Chinese patients. Can J Neurol Sci 43:703\u2013709. https:\/\/doi.org\/10.1017\/cjn.2016.261","journal-title":"Can J Neurol Sci"},{"key":"1560_CR269","doi-asserted-by":"publisher","first-page":"14941","DOI":"10.1074\/jbc.M110.211029","volume":"286","author":"W Zhou","year":"2011","unstructured":"Zhou W, Bercury K, Cummiskey J, Luong N, Lebin J, Freed CR (2011) Phenylbutyrate up-regulates the DJ-1 protein and protects neurons in cell culture and in animal models of Parkinson disease. J Biol Chem 286:14941\u201314951. https:\/\/doi.org\/10.1074\/jbc.M110.211029","journal-title":"J Biol Chem"},{"key":"1560_CR270","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.parkreldis.2022.06.001","volume":"99","author":"M Zubelzu","year":"2022","unstructured":"Zubelzu M, Morera-Herreras T, Irastorza G, G\u00f3mez-Esteban JC, Murueta-Goyena A (2022) Plasma and serum alpha-synuclein as a biomarker in Parkinson\u2019s disease: a meta-analysis. Parkinsonism Relat Disord 99:107\u2013115. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.06.001","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01560-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-025-01560-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01560-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:23:36Z","timestamp":1765535016000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-025-01560-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":270,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1560"],"URL":"https:\/\/doi.org\/10.1007\/s10571-025-01560-2","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}],"article-number":"44"}}